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Many amphiphilic molecules (surfactants) possess the ability to aggregate in aqueous 
solution to form thermodynamically stable aggregates that have potential for use as molecule 
containers and delivery systems in analytical or pharmaceutical applications.  However, it is 
difficult to release the encapsulated molecules from these aggregates under a controllable manner, 
and this problem has dramatically limited the application of these aggregated systems.  This 
study addresses this problem through fundamental structure modification by development of a 
novel redox stimuli-responsive amphiphile capable of forming vesicle aggregates.  Aggregate 
structure can be adjusted through redox stimulation. The release of agents from the core of the 
aggregates containers can be controlled by the same mechanism. 
The novel surfactant molecule, Q9 (Figure 1.3), containing a redox stimuli-responsive 
moiety was synthesized through seven synthetic steps for this purpose (Chapter 3).  The 
molecular structures were characterized by 1H NMR and mass spectrometry analysis methods.  
Properties of Q9 in aqueous solution were studied (Chapter 4).  The pH sensitivity of Q9 was 
explored in a variety of phosphate-buffered saline (PBS) solutions with UV-vis measurements 
and 1H NMR experiments; from these studies, suitable pH value was determined for Q9 vesicle 
formation.  The stimuli-responsive mechanism of Q9 was confirmed by 1H NMR kinetic studies.  
The critical aggregation concentration (CAC) was determined by surface tension measurements.  
Q9 vesicles were formed by the extrusion technique (Chapter 5).  Vesicle characterizations were 
evaluated using transmission electron microscopy, light scattering, cryo-electron microscopy and 
asymmetrical flow field-flow fractionation.  Q9 vesicles were used to encapsulate the model 
guest calcein (Chapter 6).  Size-exclusion chromatography was used to isolate Q9 vesicles 
containing dye calcein.  The successful release of calcein from Q9 vesicles was triggered by use 
of a chemical reducing agent as observed by the time-dependent increase in calcein fluorescence. 
 xvi
Based on the data, it appears that the loading volume and number density of Q9 vesicles dictates 




CHAPTER 1. INTRODUCTION 
1.1 Research Goals 
The goal of this research is to develop a novel molecular container and delivery system 
based on the aggregation of surfactants that can be controlled and adjusted by redox stimulation.  
This new stimuli-responsive system has potential for application in drug delivery systems or for 
dispensing reagents in microfluidic analysis devices.1-4 
Amphiphilic (surfactant) molecules contain both a hydrophobic and a hydrophilic domain 
within its molecular structure and can assemble together to form various morphologies.5  
Research has confirmed that these aggregates make excellent agent containers or delivery 
systems; however, the ability to release the encapsulated agents from these aggregates in a 
controllable manner presents a technical barrier.  This problem has dramatically limited the real 
application of these systems.  The study in this dissertation addresses this problem through 
fundamental structure modification: by use of a redox stimuli-responsive moiety as part of an 
amphiphilic molecule that is capable of forming aggregates.  Aggregate structure and 
morphology can then be adjusted by changing structure of the amphiphilic molecule by redox 
stimulus, and the release of reagents from the aggregate core can be controlled (Figure 1.1). 
 
 Redox-cleavable amphiphile 
Guest 
Redox Stimulation 
Figure 1.1 Release of reagents from the core of a vesicle. 
 1
Novel amphiphilic molecules containing redox stimuli-responsive functional group were 
synthesized for this purpose.  The new molecules were characterized and determined to be the 
desired structures.  Upon confirmation of the redox stimuli response of these molecules, 
aggregates were formed in aqueous environment, and their properties were studied by advanced 
analytical methods.  Encapsulation and controllable release properties have also been studied by 
monitoring the leakage of a fluorescent, hydrophilic dye. 
1.2 Research Synopsis 
1.2.1 Synthesis of Novel Redox Stimuli-responsive Amphiphilic Molecules 
Quinone molecules have been studied for decades to reveal their important role as 
electron acceptors in cell membrane and light-induced biological charge separation processes.6-9  
These studies have established them as one of the well-known redox systems.  Recently, these 
redox properties have been used for the construction of advanced redox stimuli-responsive 
materials.10-12  Different redox-sensitive kinetic processes can be achieved through different 
quinone structures.  
Borchard and Cohen discovered the “tri-methyl lock” mechanism based on a quinone 
carboxylic structure with three methyl groups.13, 14  From this mechanism, if a reducing agent is 
introduced, the quinone structure will be reduced to the corresponding hydroquinone.  The three 
methyl groups (“tri-methyl lock”) of the hydroquinone structure make it conformationally 
unstable; thus, a spontaneous intramolecular cyclization/elimination reaction occurs to produce a 
lactone product (Figure 1.2).  This mechanism will be utilized in this study to facilitate the 
release of encapsulated reagents.  
A hydrocarbon chain that contains both a hydrophobic and a hydrophilic moiety is 
needed to make the surfactant molecule aggregate in aqueous solution.  Considering both 
requirements for redox stimuli-responsiveness and aggregation of amphiphilic chain structures, 
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the novel surfactant molecules were designed with specific structures (Figure 1.3): A “tri-methyl 
lock” quinone moiety was introduced on one side of the surfactant structure to give the whole 
structure redox sensitivity, and it also served as the hydrophobic part in the amphiphilic structure. 
6-Aminocarboxylic acid was used as the carbon chain in the structure, and it was covalently 
bonded with the redox-sensitive moiety through the carboxylic group on the tri-methyl quinone.  
The carboxylic group on the end of the aminocarboxylic acid molecule provided the hydrophilic 
side to the new surfactant.  In total, seven steps of synthesis were conducted to achieve the final 
surfactant molecule, which was named Q9 (6-(3-methyl-3-(2,4,5-trimethyl-3,6-dioxocyclohexa-
1,4-dienyl)butanamido)hexanoic acid) in this study. The structure of Q9 is shown in Figure 1.3.  






















reduction spontaneousR1 R1 R1
tri-methyl lock  
Figure 1.2 Tri-methyl lock reactions. 
1.2.2 Structural Characterization 
Confirmation of the desired product from each synthesis step was obtained from 1H NMR. 
GC-MS, ESI-MS, and HPLC were also used for their characterization. Once Q9 was purified, 
NMR kinetic experiments were conducted to characterize the stimuli-responsive mechanism.  
The changes in the selected proton signal intensity were monitored after redox stimulation.  
Those intensity changes were caused by the chemical structure changes that were triggered by 
the redox stimulation, and can be used to confirm the reaction mechanism.  Furthermore, the 












Figure 1.3 Structure of Q9. 
1.2.3 Study of the Properties of Novel Redox Stimuli-responsive Amphiphilic Molecules 
 
The unique properties of the newly synthesized surfactants were studied.  The pH 
sensitivity was analyzed for future application in an aqueous environment. NMR, and UV-vis 
experiments were conducted to explore any potential changes in molecular structures and/or 
properties, which are affected by different pH environments. A suitable pH value was chosen for 
the following research. 
Surface tension experiments were used to measure the critical aggregation concentration 
(CAC) of the new surfactant.  This concentration is then used as the standard for the following 
aggregation development studies. 
1.2.4    Development of New Vesicles through Aggregation 
The newly synthesized surfactant structure is similar to that of n-alkanoic acid surfactants.  
Previous studies have shown that those molecules can aggregate into vesicles under certain 
conditions.15-17  The traditional phospholipids-based vesicle generation methodology was 
adopted to create vesicles with Q9,18 and employs mechanical extrusion.  The experimental 
conditions were controlled at a suitable pH value and surfactant concentration.  After their 
formation, vesicle size was obtained with light scattering.  Advanced microscopy methods were 
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also used to study the lamellarity of the vesicles.  The disassembly of the vesicles was triggered 
by a reducing agent and monitored by dynamic light scattering and TEM.  Asymmetrical flow 
field-flow fractionation (AF4) was used to explore the size distribution of the Q9 vesicles. 
1.2.5 Encapsulation Experiment 
A water-soluble dye (calcein) was used as the reagent to be encapsulated inside the Q9 
vesicles.  Calcein is a self-quenching dye whose fluorescence is quenched when encapsulated 
inside the vesicles at a high initial concentration.  In order to encapsulate the calcein, a solution 
of the Q9 surfactant and calcein at a concentration higher than the self-quenching concentration 
was extruded.  A preparative size-exclusive chromatography column was then used to separate 
the vesicles from the free calcein.  Salt concentration and pH were controlled carefully during 
this separation process.  Fluorescence kinetic experiments were then set up to monitor the time-
dependent fluorescence signal upon application of redox stimulation.  Based on the expected 
redox-stimuli responsive mechanism, the introduction of a reducing agent should cause a 
disconnection in the surfactant and subsequent disassembly of the vesicles.  Thus, calcein is 
released, it is diluted to a value less than its self-quenching concentration, and the increase in 
calcein fluorescence can then be observed. 
1.3 Background 
1.3.1    Vesicle Aggregation 
Surfactant molecules, also called amphiphilies, contain both a hydrophobic part and a 
hydrophilic head group.  When these molecules are dissolved in an aqueous solution, the 
hydrophobic part tries to minimize the contact area with water molecules.  This phenomenon is 
called the hydrophobic effect and can cause the formation of different aggregates.19  Inside the 
structure of aggregates, a concentrated hydrophobic part is surrounded by the hydrophilic moiety 
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that contacts water molecules directly.  This construction produces macro-homogenous systems 
(solution) with many “different” micro-phase structures (aggregates) inside.   
Based on the variety of molecule structures, solution systems, and treatment methods, 
amphiphilic molecules can aggregate into different morphologies that include ordinary and 
inverse micelles, liquid crystals, bilayers, vesicles, and microemulsions.20 Among them, research 
on vesicle structures has become increasingly important, because these aggregates possess 
potential for use as water-soluble reagent containers and delivery systems.  
A bilayer structure formed by amphiphilic molecules is the basic construction unit for 
vesicles (Figure 1.4).  The amphiphilic molecules are well organized inside the vesicles: the 
hydrophilic polar heads face the aqueous surroundings, and the hydrophobic parts constitute the 
interior of the bilayer.  In the simplest case, the bilayer just forms planar structures (Figure 1.4); 
however, it is possible that the bilayer can be curved to form closed, spherical objects called 
vesicles.  Vesicles can be many different sizes, such as small unilamellar vesicles (SUV, radius 4 
– 20 nm), large unilamellar vesicles (LUV, radius 50 nm – 10 µm), and multilamellar vesicles 
(MLV).  Generally, unilamellar vesicles are more likely to be observed in dilute systems, while 
MLVs are typically found in concentrated systems.  
 
 





The formation of vesicles from surfactants can be achieved through dispersion of lamellar 
bilayer, by dilution, input of external force, or spontaneously depending on amphiphile 
molecular structure.  The detailed mechanism for each condition is still under investigation.  
Traditionally, three classic techniques are used to cause formation of phospholipid vesicles: 
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sonication, thin-film hydration, and extrusion.18  Among them, the extrusion technique is the 
most widely used.  Using this technique, multilamellar surfactant is pushed through an extruder; 
the strong shear force reorganizes the lamellar sheet structure into vesicles.  A membrane filter 
with a given pore size will cause phospholipids to form vesicles of approximately same size as 
the membrane pores.21  
Phospholipid vesicles have been studied for a long time as classic vesicle models.  These 
particular vesicles are formed by phospholipid molecules that usually possess two hydrophobic 
chains as the “tail” structure.  Recent research has confirmed that vesicles can also be generated 
by single-chain surfactants.15, 22, 23  It has been suggested that these single-chain vesicle 
aggregates performed an important role in the early stages of life.24  Szostak pointed out that 
these vesicles can provide a spatial microenvironment for photo-metabolic reactions, or a 
mechanism for the spatial confinement of genetic polymers.17   
Walde studied single-chain vesicles formed by decanoic acid,22 whose structure is such 
that micelle aggregates form in aqueous solution.  Based on Walde’s study, the ionization status 
of decanoic acid affects aggregate formation.  Highly deprotonated decanoic acid (decanonate) 
easily forms micelles; however, when the ratio of unionized decanoic acid is increased in 
solution, vesicles can be formed.  Walde mixed decanoic acid and the corresponding decanonate 
salt together under a variety of concentrations, and applied the titration method to adjust the pH 
of these solution systems (Figure 1.5).  
The experiment results showed that these solutions undergo similar changes even though 
the concentrations are different.  The solutions remained transparent if the pH was greater than 
8.1, which indicated predominately micelle-style aggregates in the solution when decanoic acid 
was highly deprotonated.  When the pH was decreased to 8.1, the solution started becoming 
turbid, indicating a change in aggregate formation.  Using microscopy, the cause of these 
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changes has been confirmed to be the result of vesicle formation.  To confirm this result, a mixed 
solution of acetic acid and the corresponding acetate salt has been used to perform the same 
titration experiment.  No phase change can be observed during the pH adjustment because no 
aggregates were formed using this system.  Walde pointed out that when the pH was decreased 
into the range of 6.5 to 8.1, a well-balanced solution of protonated and deprotonated decanoic 
acid was achieved, and this balanced condition was key to form the vesicles.  
 
Figure 1.5 Titration experiments on (decanoate + decanoic acid) and (acetate + acetic acid) 
system. Adapted from Ref 22. 
 
Blanchard also studied this decanoic acid solution system25 and clearly confirmed that 
vesicles form from this single-chain amphiphile between pH 6.5 and 8.1 at concentration 100mM.  
The formation of micelles and vesicles could be observed from this single-chain surfactant 
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solution by TEM studies (Figure 1.6). These research results indicate that ionization plays an 
important role in aggregate formation from these single-chain fatty acid surfactants, and pH can 
be adjusted to control the aggregate type so as to generate vesicles. 
 
 
Figure 1.6  TEM image of decanoic acid/decanoate (a) vesicles  and (b) micelles. Adapted 
from Ref 25. 
 
Szostak studied the growth of this kind of vesicle from another point-of-view: 
transforming the micelles into vesicles.16  It was pointed out that these fatty acid vesicles possess 
different properties in comparison to those phospholipid vesicle counterparts.  One difference is 
that although these vesicles still exist as stable supramolecular structures, their molecular 
components are in a rapid, dynamic exchange process with the surrounding solution and with 
each other.  It has also been suggested that the spontaneous assembly of fatty acid vesicles from 
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alkaline micelles is an autocatalytic process.  A certain sized oleate vesicle was used as a seed to 
initiate growth of the vesicles by incorporating additional oleates supplied by oleate micelles.  
Fluorescence was used to follow fatty acid vesicle growth.  A non-exchanging, membrane-
localized fluorescence resonance energy transfer (FRET) dye was applied here to measure the 
increase in vesicle surface area as the micelles transfer into vesicles.  The experimental results 
showed that there are two mechanisms for vesicle size increase (Figure 1.7). In one mechanism 
oleates were transferred from micelles into vesicle directly by coating the preformed vesicles. In 
another mechanism, oleates formed aggregated intermediates first, then transferred into vesicles.  
The vesicle formation process is hard to control and monitor. This study provides a novel 
way to observe how single-chain fatty acid vesicle size can be changed by adopting micelles 
surrounded in the solution.  This finding will be useful on the monitoring of vesicles size change 
in the future vesicle studies. 
Growing
Vesicle









In another article published by William R. Hargreaves and David W. Deamer, C8-C18 
single-chain carboxylic acid amphiphiles were studied to understand the physicochemical 
conditions for the formation of membrane structures.15  A variety of characterization techniques 
were applied in this research to image vesicles, such as trapping of ionic dyes, negative-stain 
microscopy, and freeze-fracture electron microscopy.  One interesting new method, phase-
contrast microscopy, was utilized to image the vesicles wherein some solutes such as sucrose 
were added into the vesicle solution, which then creates differences in the refractive index to 
make vesicles appear brighter in the microscope. 
1.3.2    Redox-responsive Aggregates 
The stable chemical environment inside the aggregates, their nanometer size, and their 
long-term storage stability have enabled vesicles to be used in many different areas.  For 
example, vesicles can be used as drug delivery systems to transport drugs to target position and 
protect those drugs from elimination by the body’s immune system.26, 27  Vesicles can also be 
used as reagent-dispensing systems to delivery reagents in microfluidic analysis devices to 
enable advanced lab-on-a-chip technology. 1 
Although vesicles have many advantages for a variety of applications, there does exist a 
technical barrier to overcome in order to utilize vesicles system: the controlled release of the 
encapsulated reagents from the vesicles.  Researchers have tried different methods to achieve this 
control.  Many of those works have focused on solving this problem from a fundamental 
structure point of view: to modify the surfactant structures to give them specific stimuli-
responsive properties.4, 28-30  The aggregates formed from these surfactants are easily controlled 
by the same stimulation mechanism.  Although some systems have been developed using this 
idea, their structure and properties are not well-defined.  More studies still need to be conducted 
in order to develop new systems. 
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Redox-responsive surfactants are good candidates for stimuli-responsive structures by 
providing precise control over the disassembly of vesicles (through a reducing agent or an 
applied potential).  Generally, these structures have a redox-sensitive functional group within the 
molecular structure.  Upon a redox-stimulation, the structure of those sensitive groups changes 
and initiates the disassembly of the vesicles. 
Many scientists have tried to synthesize these redox-responsive surfactants with different 
functional groups.  For example, the Manners group has synthesized a new redox-sensitive 
amphiphilic structure,4 a diblock copolymer that employs polydimethylsiloxane (PDMS) as a 
hydrophobic block and polyferrocenylsilane (PFS) as a hydrophilic block.  Based on their 
experiments, this newly synthesized amphiphilic structure can self-assemble into vesicles in 
water and has been confirmed by TEM experiments.  PFS is an electroactive block that is 
controlled by redox stimulations.  The previous study has shown that the redox reaction of the 
ferrocenyl group causes the change in the hydrophilic property of the surfactant. 31, 32  It is 
predicted that vesicles generated by this diblock copolymer can be controlled by redox-
stimulations; however, the goal of this project has yet to be demonstrated.  Although the 
structure is well-designed and vesicles are formed, no evidence has been shown that vesicles 
morphology can be adjusted by redox stimulation.  No reasons were cited for this, which 
indicates more research is still needed on this system. 
Bhattacharya’s group30 has also developed three new surfactant structures that use an 
anthraquinone moiety as the redox-sensitive group.  A hydrocarbon chain structure is covalently 
attached onto the anthraquinone.  Based on their study, vesicles can be formed by sonicating 
these surfactants for several minutes in water.  Anthraquinone is a redox-sensitive group that can 
be reduced into the corresponding hydroquinone upon introduction of a reducing agent or 
application of a reducing potential.  Once it is reduced, the polarity of the group dramatically 
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changes; thus, vesicle morphology can be adjusted. UV-vis experiments have clearly shown the 
production of the hydroquinone product after introduction of dithionite (S2O42-), confirming that 
the designed mechanism is working. However, no guest release studies have been demonstrated 
to date. 
Some strategies to develop new redox-responsive surfactants can be derived from these 
examples discussed above: choose a redox-sensitive moiety as the polar group and attach a 
hydrocarbon chain covalently-bonded to a hydrophilic head group.  Previous works confirmed 
that these kinds of amphiphilic structures can aggregate into  
vesicles.4, 30  Meanwhile, the polarity change caused by redox-stimulation is capable of changing 
the amphiphilic nature of molecules and disassembling the vesicles to controllably release the 
payload.  Studies have shown some progresses in developing redox-responsive aggregates, but 
the properties of those developed systems are still not well-defined. 4, 30 
Although ferrocenyl has been confirmed as a redox-sensitive structure in previous studies, 
it can not be shown if this redox reaction will actually drive the change in vesicle morphology 
that is described in Manner’s paper.  The work from Bhattacharya’s group is encouraging, but 
their vesicles can only remain stable in storage for several hours based on light scattering data 
(suspected that the anthraquinone group photo-decompose), which will limit their application.  
Clearly, the development of new redox-responsive aggregates is very challenging work due to 
the difficulties with new surfactant syntheses, the complex mechanism of vesicle formation, and 
the limited methods for disassembling vesicles.  
1.3.3    Quinonoid Compounds 
Quinonoid compounds have been studied over many decades as the prototypical example 
of organic redox systems.33  Usually, they are ring structures containing a cross-conjugated 
system. Quinone compounds can undergo electrochemical reactions, and the reduced 
 13
hydroquinone product will have a different polarity from the initial quinone structure.  The half-
reaction is a reversible reaction:    
                                                        Equation 1.1 
A particular quinone compound has been found to play a very important role in biological 
activity for most living systems during the synthesis of adenosine triphosphate (ATP).34, 35  In the 
1960s, people already knew that ATP was the energy source for most of life, but it was still 
unclear how ATP was generated until Nobel Laureate Peter Mitchell illustrated his chemiosmotic 
theory.  Based on this theory, it is an electrochemical gradient generated in the cell membrane 
that drives the synthesis of ATP.34, 36  A series of redox processes generate the electrochemical 
gradient in the cell membrane, and a quinone compound called ubiquinone performs a very 
important role to make these processes work normally.  
 
Figure 1.8 Structure of ubiquinone. 
Ubiquinone is a lipid-soluble structure and is able to move freely inside the cell 
membrane, enabling ubiquinone molecules to shuttle electrons between immobile, larger 
complexes that are imbedded inside the cell membrane.  The redox reactions of ubiquinone are 
similar to the redox reactions of other quinone structures.  It is very interesting to see that even 
nature has utilized quinone redox properties for one of the most important processes in life.  
Furthermore, cell membranes resemble a vesicle structure; the presence of ubiquinone in this 
environment indicates the possibility for future incorporation of quinones in “artificial” vesicles. 
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Recent studies have shown that quinone compounds can also work as bioactive drug 
candidates for tumor cell treatment.10, 37-39  DT-diaphorase is a quinone oxidoreductase enzyme 
that exists in a wide variety of cells,40 and it can reduce quinone compounds to the corresponding 
hydroquinone.  Researchers at the National Cancer Institute have screened a variety of tumor cell 
lines to check their specific enzyme activities.38  Three different enzymes were chosen for these 
studies, and the results showed that for every scanned tumor cell line, DT-diaphorase presented 
an obviously higher enzyme activity compared to the other two enzymes included in the study.38  
This extremely high enzyme activity for DT-diaphorase in cancer cells could be used as the 
trigger for the stimuli-response reaction mechanism, the reduction of quinone-based bioactive 
compounds will cause the degradation of the vesicle and release of the anti-cancer drug. 
1.3.4    “Tri-methyl lock” Mechanism of the Quinone Compound 
In 1972, Cohen and Borchard published their research concerning a series of quinone 
compounds that contained a 3-methylene carboxylic acid, a compound capable of undergoing a 
ring cyclization/lactonization reaction upon reduction to the hydroquinone.13, 41, 42  These 
structures and the corresponding ring cyclization/lactonization reactions have been studied in the 
following years; new stimuli-responsive molecules were designed from these studies. 12 
 
Figure 1.9 “Tri-methyl lock” mechanism.  
Research has shown that molecular structures containing two methyl groups at the 
benzylic position together with a proximal methyl group on the ring, referred to as the “tri-
methyl lock”, will exhibit enhanced lactonization rates.  Upon reduction, an intramolecular 
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cyclization/elimination reaction occurs automatically following the formation of the 
hydroquinone; hence, the “tri-methyl lock” mechanism.  The spontaneous lactonization reaction 
occurs because the three methyl groups create increased strain energy on the ring structure, 
which facilitates nucleophilic attack at the carbonyl carbon.  The “tri-methyl lock” mechanism 
and the structures of the compounds involved in this process are shown in Figure 1.9.12   
By varying the functional group (XR) adjacent to the carbonyl, the “tri-methyl lock” 
mechanism can be extended to other applications that also utilize this cyclization/elimination 
event.  For example, researchers have used these “tri-methyl lock” quinone structures to develop 
prodrugs as delivery systems wherein HXR is some kind of drug.  In particular, Borchardt and 
coworkers have reported that hydroxyl amide lactonization can be used as a potential esterase-
sensitive amide prodrug.37-39  The mechanism for the redox-sensitive and esterase-sensitive 
system is shown in Figure 1.10.39 
 
Figure 1.10 Mechanisms for utilizing “tri-methyl lock” mechanism for prodrug release.  
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In this application, the quinone moiety can be reduced under certain chemical conditions 
(step 1b), and then the following intermediate undergoes lactonization to release the potential 
drug compound (step 2).  If an ester moiety is present on the hydroquinone, then the rate of 
lactonization depends on the rate of enzymatic or chemical hydrolysis of the initial structure 
(step 1a).39  These structural designs helped to develop a prodrug system that is triggered by 
either an esterase or reducing agent. 
Another paper, published by Mrksich’s group, described a double side-chain structure 
that is also based on a “tri-methyl lock” quinonoid compound.43  The purpose was to develop a 
new class of dynamic electroactive monolayers on surfaces that can selectively release 
immobilized ligands, which is very important to bio-interfacial science studies.  The monomer 









Figure 1.11 A quinone propionic ester with a bi-functional group. 
 
The side chain containing the double bond in Figure 1.11 was used to connect the self-
assembled monolayers (SAMs) of alkanethiolates onto gold surfaces while the other side with a 
terminal amine was used to capture biotin ligands.  When a reduction potential was applied 
through gold, the quinones convert into the corresponding hydroquinones, which then undergo 
the cyclization/elimination reaction and release the biotin ligand.  The “tri-methyl lock” in this 
structure serves to increase the rate of biotin release.  This study combines self-assembly 
monolayer, the redox property of quinone structures, and biotechnology to demonstrate the great 
potential for mechanistic studies in cell biology. 
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CHAPTER 2. MATERIALS AND METHODS 
 
2.1       Chemicals 
 
The following chemicals were purchased from Sigma-Aldrich and used as received: 
trimethylhydroquinone (97%), methanesulfonic acid (99.5%), dimethylacrylic acid (97%), ethyl 
acetate (99.5%), sodium bicarbonate (99.5%), sodium chloride (99.5%), magnesium sulfate 
(99.9%), deuterated chloroform (99.9 atom%), anhydrous tetrahydrofuran (99.9%), triethylamine 
(99.9%), anhydrous dichloromethane (99.9%), potassium carbonate (99%), hexane (99%), 
anhydrous chloroform (99.9%), 
N-bromosuccinimide (99%), 1,3-dicyclohexylcarbodiimide (99%), acetonitrile (99.9%), acetone 
(99.9%), 10% palladium on carbon catalyst powder, ethanol (99.9%), fuming sulfuric acid (18M), 
formic acid (96%), sodium dithionite (85%), calcein (93%), sodium phosphate dibasic (99%), 
sodium phosphate monobasic (99%), sodium phosphate (96%),  isobutylene (99%).  N-
hydroxysuccinimide (Aldrich 97%) was purified by recrystallization prior to experiments.   
Additionally, N-benzyloxycarbonyl-6-aminohexanoic acid (Novabiochem, 90%), sephadex G25 
gel (GE healthecare), sodium hydroxide (Fisher, 98.6%), 32-63 µm neutral silica gel having 6 
nm pore size (Alltech), silica gel TLC plate (Alltech), were also used in these experiments.   
Water for these experiments was purified and deionized (18 MΩ-cm) through the use of a 
Barnstead-Nanopure water filtration system. 
2.2       Methodologies 
2.2.1    Extrusion Technique for Development of Vesicle Aggregates 
Solid Q9 (2.1 mg) was dissolved in 10 mL dichloromethane (DCM), and the solvent was 
evaporated under vacuum in a round bottom flask (RBF) to form a dried homogenous Q9 thin 
film.  Phosphate buffered saline (PBS) solution (50 mM with NaCl 50 mM, 0.7 mL, pH 7.8) 
solution was filtered through a sterile Anotop filter (Whatman, 0.02 µm pore size/10 mm 
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diameter), and added into the RBF to hydrate the Q9 dried film for 2 hours.  The flask was then 
vortexed for 15 mins.  A hand-held, mini-extruder from Avanti Polar Lipids with 100 nm pore 
size Nuclepore polycarbonate track-etched membrane (6-11 µm thickness) was used to extrude 
21 repetitions the Q9 molecules for forming vesicles, Figure 2.1. 
 
 
Figure 2.1 Extrusion. 
Before the experiment, one polycarbonate track-etched membrane (Nuclepore,100 nm, 6-
11 µm thickness) was fitted in the middle part of extruder across the internal solution channel. 
Two Gas-Tight syringes were connected on each side of the solution tube.  One syringe was 
filled with vortexed 10 mM Q9 in pH 7.8 PBS. This syringe was pushed by hand to force the 
solution through the membrane into the opposing syringe. Then it was pushed back to the 
original syringe.  This process was repeated 20.5 times.  The strong shear force generated as the 
solution is pushed through the membrane promotes vesicle formation.1-3 
2.2.2    Preparation of Samples for Light Scattering 
All sample cells for the LS experiment were thoroughly cleaned to remove any dust. The 
cleaning procedure included sonicating glass sample cells for 20 mins, a rinse in Nano-pure 
water, and drying in a laboratory oven. 
Q9 solutions were prepared in pH 7.8 PBS solution (50 mM with NaCl 50 mM) and then 
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ated through the extrusion process as described above. The extruded samples were placed 
in the dust-free sample cells for the LS measurement.  
2.2.3    Dynamic Light Scattering  
Dynamic light scattering is a technique that
scattering light intensity through a liq
ution undergo a “random walk” based on the theory of Brownian Motion.  Thus, the 
diffusion coefficient value (D) of sample particles can be derived from the change of scattered 
light intensity in the time frame of a given experiment.  The autocorrelation functions recorded in 
the experiment make the measurement of D possible. If the particles present as a spherical 
structure, The Stokes-Einstein equation (Rh=kT/6πηD) can be applied in order to calculate the 
hydrodynamic radius of a given particle.4 
Dynamic light scattering experiments were conducted using a Zetasizer Nano Instrument 
(Malvern, Worcestershire).  Carefully cle
ng to the preparation of sample cells referred to the section 2.2.2.  Experiment 
temperature was held constant at 25 oC and was stabilized before the measurement.  The buffer 
viscosity parameter was calculated by the software of the instrument using the concentration of 
the sodium phosphate present.   
2.2.4    Surface Tension Measurement 
Surface tension measurem
tensiometer (KSV Instruments, Monroe, C
 5.99 cm mean circumference (CSC Scientific, Fairfax, VA) was hung on a microbalance.  
The force applied to this ring was recorded through this microbalance.  
A 2.0 mL solution sample of Q9 was placed in a home-made 10 mL glass cup.   The 
platinum ring was cleaned with ethanol and dried under a nitrog
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each time the maximum force on the ring was recorded as the surface tension.  Average values of 







sion measurement by du Nuoy ring method. 
In order to calculate the CAC of Q9, a series of surface tension m
conducted on Q9 samples.  Eleven Q9 samples were prepared in PB
50 mM, pH 7.8) with the concentrations ranging from 0.2 mM to 14 mM.  
 Samples were tested from the highest concentration to the lowest concentration.  The surface 
tension of pure solvent (buffer) was also measured, giving the highest value in this series of 
experiment results.  A surface tension versus concentration curve was plotted and the CAC value 
was determined from this curve.  
2.2.5    Theory of Critical Aggregation Concentration 
When surfactant molecule
interface because of the insolubility of the hydrophobic m
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d to separate and characterize particles in solution.6-8  The 
ion, another flow 
of the s
f the molecule is oriented in the air phase.  The concentrated hydrophobic structure at the 
interface results in a decrease of surface tension.  
Concentrated surfactant at the air-water interface allows for a increase in the repulsive 
forces between adjacent molecules.  When the con
n force is big enough to prevent more surfactant being taken up at the interface.  Thus, 
aggregation of molecules ensues.  The concentration at this moment is called the critical 
aggregation concentration (CAC).  Above the CAC, any further surfactant added into the 
solution forms aggregates instead of inserting at the water-air interface.  The surface tension 
should stay relatively stable regardless of whether more surfactant is added to the solution. 
This surface tension property can be used for the determination of the CAC.  Generally a 
group of water solutions is prepared having different surfactant concentrations.  The su
 of each solution is measured.  In the low concentration range, the surface tension 
decreases as a result of the increasing surfactant concentration due to the migration of the 
surfactant to the air-water interface.  When the surfactant concentration is above the CAC, the 
surface tension becomes stable due to the formation of aggregates.  Thus, the surface tension 
data can be plotted versus solution concentration; the concentration related to the “turn over” 
point in this plot will be the CAC.5 
2.2.6    Mechanism of Asymmetrical Flow Field-Flow Fractionation (AF4)  
AF4 systems were develope
sample is injected into a channel with a lamellar flow along the channel direct
ame solvent system is applied orthogonally to the first flow by passing solvent through a 
membrane on the bottom of the channel.  The membrane through which the orthogonal flow 
passes is designed to have size-exclusion capabilities; the pore size of the membrane is smaller 
than the sample particles to prevent the injected sample particles from being lost.  Thus, particles 
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inside the sample are pushed closer to the membrane as they move through the channel carried 
by the lamellar injection flow.  Those particles present different distance from the membrane as 
well as the different flow rate, as they are carried in the lamellar flow, depending on their sizes 
and the strength of the orthogonal flow.    Finally, they will elute out at different times due to 
flow velocity differences.  The mechanism of this technique is shown in Figure 2.3.  To achieve 
the best separation result, both the lamellar and orthogonal field flow is adjusted to optimize 
particle separation by adopting different programming methods.  The programmed  
field-flow method is called AF4 technology and it was applied to the Q9 system.6-9 
 
Figure 2.3   The mechanism of AF4 separation based on the particle sizes.  Adapted from 
Reference 7. 
 
2.2.7    AF4 Studies on Extruded Q9 Sample 
regates were separated using an Eclipse 2 AF4 system (Wyatt Technology Corp., 
stem (Agilent 1100 isocratic pump, Agilent 1100 
autosam
Technology Corp., Santa Barbara, CA); an Optilab rEX Differential Refractive Index detector 
Q9 agg
Santa Barbara, CA).  An Agilent 1100 HPLC sy
pler, and Agilent 1100 degasser, Agilent Technologies, Palo Alto, CA) was used for 
injection of the samples and delivery of solvent through the AF4 system.  The AF4 channel was 
assembled with a 350-µm-thick Mylar spacer; the membrane used was made of regenerated 
cellulose with a 10 kDa molecular weight cutoff (Wyatt).  Three detectors were used for the 
analysis: a Heleos, multi-angle light scattering (MALS) with a QUELS (DLS) detector (Wyatt 
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(Wyatt Technology Corp., Santa Barbara, CA) at 658 nm; and a Waters 484 UV-Vis detector 
(Waters, Milford MA) at 280nm.  Data acquisition of the root mean squared (rms), and 
hydrodynamic radius (Rh) value were calculated using Astra V software (Wyatt).  
For the experiment, PBS solution (3.0 L, 50 mM with NaCl 50 mM, pH 8.0, containing 
200 ppm NaN3) was prepared at 40 mM concentration, then filtered through a 100 nm membrane 
for use as the mobile phase.  Q9 aggregate samples (3.0 mg/mL) and DOPC vesicle samples (1.0 
mg/mL
arious particle sizes in polymer and biological studies.10  In this research it was 
tions having particles with polydisperse 
size dis
the hydrodynamic shielding effect.  Big 
me PBS that was used for the eluent (pH 7.8) for 10 
) were prepared in the same buffer solution by the extrusion method with a 100 nm 
membrane.  The DOPC sample was used as the reference for the flow control method 
development.  
2.2.8    Preparative Size-Exclusion Chromatography 
Size-exclusion chromatography is widely used to separate and characterize particle 
samples with v
used to separate Q9 vesicles in solution.  Sample solu
tribution are introduced into a preparative  
size-exclusion chromatography column that is packed with beads of porous material.  Small 
particles in the solution can go into the pores inside these beads.  Thus, they move slowly there 
until they exit from the pores because of 
particles/molecules can not enter the pores; they move rapidly through the void volume between 
the beads.  Thus, different particles elute from the column at different times: big particles move 
out quickly, small particles come out later.  
The preparative size-exclusion column used here is an in-lab prepared column.  Sephadex 
G25 gel (GE Healthecare, Piscataway, NJ ) was used for the column packing medium.  The 
sephadex gel (10 g) was hydrated with the sa
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hours, 
volume of PBS solution in the burette was maintained to act as the mobile phase.  
Particle
centration of calcein in pH 7.8 PBS (0.1 M with 0.1 M NaCl) was 
alcein was self-quenching under this 
concen
400-Cu-25).  For 
then poured slowly into a 100.0 mL titration burette and allowed to settle in order to pack 
the column.  
The particle separation was conducted under air pressure.  Q9 vesicle samples that were 
developed by the extrusion treatment were introduced at the top side of the column via a glass 
pipette.  The 
s were separated based on the theory explained above. The effluent was collected at 
consistent time increments as samples to be analyzed.  In accordance with the mechanisms 
working in the preparative size-exclusion column, Q9 vesicles were contained in the earliest 
collected effluent samples. 
2.2.9    Dye Encapsulation and Release Experiment 
Calcein, a water-soluble dye, was explored to study the encapsulation ability of Q9 
aggregates.  A 50 mM con
extruded simultaneously with 3 mg/mL of Q9. C
tration.  The concentrated calcein was maintained, as well as the self-quenching status, 
when it was encapsulated inside the Q9 vesicles, because the Q9 vesicle protect it from dilution 
in the PBS solvent.11  The extruded solution was eluted with pH 7.8 PBS solution (0.1 M with 
0.1 M NaCl) through an in-lab prepared size exclusion column (sephadex G25 gel, GE 
healthecare) to separate the calcein-containing Q9 aggregates from free calcein.  After separation 
by preparative size-exclusion column, the fluorescence intensity of Q9 aggregates containing 
calcein was monitored with a luminescence spectrometer (PerkinElmer, LS50B, Waltham, MA) 
in order to observe the impact of adding Na2S2O4, a chemical reducing agent. 
2.2.10 Preparation of Samples for Transmission Electron Microscopy 
Microscope grids and a storage box were purchased from Electron Microscopy Sciences.  
Grids used for experiments were the 400 mesh carbon-coated Cu type (CF
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sample analysis, the grid was carefully placed into a 150 mm x 15 mm polystyrene Petri dish 
cover (
e grid onto the sample holder inside the TEM microscope.  Liquid nitrogen was 
used a
nstruments, including a 
PX-400. 1H kinetic experiments were performed on Bruker ARX-300 
room temperature.  For 1H NMR 
kinetic 
Fisher Scientific) with carbon side facing up. One small drop of sample solution was 
deposited on the grid with a 2 µL micropipette.  Five minutes later, it was removed by blotting 
with a small piece of sterile filter paper, being careful not to displace the aggregate sample 
attaching to the grid while blotting.  A negative stain method was used for sample imaging.  A 
small drop of 2% uranyl acetate (UO2(CH3COO)2·2H2O water solution was deposited on the 
sample loaded grid, and allowed to sit for 2 mins before removed by blotting as previous 
described.12, 13 
A JEOL 100 CX transmission electron microscope with an electron acceleration voltage 
of 80 kV was employed for the experiment (JEOL USA, Inc., Peabody, MA).  Tweezers were 
used to place th
s the cooling agent during the experiment process.  Kodak electron microscope film 
(vendor number 1662238) with dimensions of 3.25" x 4" was used for the experiments and was 
developed and fixed according to the operation menu from Kodak.  Negatives were scanned into 
a computer and edited with Photoshop software (Adobe, San Jose, CA). 
2.3       Instrumentation 
2.3.1    Nuclear Magnetic Resonance Spectroscopy (NMR) 
Proton NMR experiments were performed on several Bruker i
DPX-250, ARX-300 and D
instrument.  All these experiments were conducted under at 
studies, 23 1H NMR experiments were run for 300 minutes after the addition of 5 
equivalents of solid reducing agent, Na2S2O4.  During each experiment, NMR spectra were 
recorded at various time points to measure the change in proton signals during the 300 mins 
experiments.  Each 1H NMR spectrum was integrated to achieve the relative area of the 
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absorption peaks for each experiment.  The change in area of selected peaks was used as the 
index to monitor the reaction kinetic process.  
2.3.2    Gas Chromatography Mass Spectrometry (GC-MS) 
GC-MS analysis was performed with a Varian Saturn 2200 GC/MS (Varian, Palo Alto, 
CA).  This instrument was equipped with a CP-3800 GC and the 2000 Series Ion Trap MS with 
lvent for the sample preparation.  
The ma
 LC system was utilized for high-resolution ESI-MS analyses.  Samples were measured 
2.3.4   
aging by means of 
od enables the sample to retain its solution 
propert
  
an automatic injection mode.  Chloroform was used as the so
ss range of the instrument is from 10 to 650 m/z. Software utilizes a DB5 control method 
for all analyses (Injector temperature 250 ºC, flow pressure 0.1 psi, column oven temperature 
280 ºC). 
2.3.3   Electrospray Ionization Mass Spectrometry (ESI-MS) 
An Applied Biosystems (Foster City, CA) QSTAR XL quadrupole time-of-flight MS 
with nano
with a mass accuracy below 4 parts per million (ppm).  
 Cryogenic Electron Microscopy (CryoEM) 
CryoEM experiments were conducted at National Center for Macromolecular Image 
(Baylor College of Medicine, Houston, TX). The sample was prepared for im
vitrification of frozen hydrated samples.14  This meth
ies with the fewest possible artifacts.  A Quantifoil (Quantifoil Micro Tools EmbH, Jena 
Germany) 400 mesh holey carbon copper grid was placed in the Vitrobot (FEI, Hillsboro OR) 
where temperature and relative humidity were regulated.   The 2.5 µL aliquot of sample was 
applied to one side of the grid, filter paper was used to remove excess liquid on the grid by an 
automatic blotting process.   Then the grid was rapidly plunged into a cup of liquid ethane, 
thereby freezing the sample almost instantaneously.  Vitrification of the sample on the grid was 
achieved during this process; the resulting “glues” can be examined by the electron microscopy.  
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The grid was then transferred to a storage holder submerged in a liquid nitrogen tank where it 
was kept until use (in 7 days).    Microscopy was carried out using a JEOL 2010F transmission 
electron microscope (JEOL, Tokyo Japan) operated at 200 kV under loose dose conditions, and 
the specimen was maintained at -203 ºC by a Gatan Model 626 cryostage (Gatan, Pleasanton 
CA).   Images were recorded with Gatan US4000 4k x 4k charged-coupled device (CCD, Gatan, 
Pleasanton CA) camera and processed using the EMAN software package.15  
2.3.5    Ultraviolet-visible (UV-vis) Spectroscopy 
UV-vis absorption measurements were performed on a Cary 50 Bio UV-vis Spectrometer 
(Varian, Palo Alto, CA).  The emission source in this instrument is a Xenon flash lamp and is 
h from 200 to 1000 nm in 80 seconds.  Scan 
ranges 
ts.  A pulsed Xenon discharge lamp (7.3 W average power at 50 Hz) 
 the operation of the instrument was controlled with FL 
Winlab
encapsulated; the excitation wavelength (495 nm) and the emission wavelength (515 nm) of 
able to scan a sample through a range of wavelengt
were selected depending on the solvent system used and the purpose of analysis.  Medium 
scan rate was chosen.  A quartz cuvette or a polystyrene UV-vis cuvette (Fisher Scientific, 
Pittsburgh, PA) with 1.0 cm path length were used as the sample cells for the absorbance 
measurements.  Before each sample measurement, a “blank” sample (solvent) was run to allow 
for background subtraction. 
2.3.6    Fluorescence Spectrometry 
An LS 50B Fluorescence Spectrometer (Perkin Elmer, LS50B, Waltham, MA) was used 
for fluorescence measuremen
was utilized as the light source and
 software.  The software enabled a dynamic process measurement up to 1500 minutes 
with adjustable interval time scale measurements of the fluorescence intensity change.  A 10×10 
mm (3.5 mL) quartz cell was used as a cuvette during analysis.  
Dynamic fluorescence experiments were conducted on Q9 vesicle samples with calcein 
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calcein were used in the dynamic operation mode to monitor the fluorescence change of the 
sample.  The whole dynamic experiment time was continued for 1500 minutes; the fluorescence 
intensi
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CHAPTER 3. SYNTHESIS OF A NOVEL SURFACTANT 
.1       Introduction 
The first goal of this project is to synthesize a novel, stimuli-responsive surfactant 
ontaining a quinone moiety as the redox-active trigger.  The reduction of quinone compounds 
can be easily ach n be monitored 
  Thus, the redox sensitivity of this new surfactant structure can be 
charact
ve structures based on the tri-methyl lock mechanism; however, most of these 
system





ieved through multiple methods,1-4  and the reaction process ca
by kinetic studies.5-10
erized. 
The first chapter introduced the redox mechanism of tri-methyl lock quinone structures, 
which readily to conduct cyclization reaction due to the unique high strain energy of the tri-
methyl lock structure.6, 8, 11, 12  Many researchers have already successfully developed and studied 
redox-responsi
s were designed for pro-drug applications. 13-15
In this study, the tri-methyl lock quinone structure will be used to build the redox-
responsive property into the novel surfactant molecule, while a hydrocarbon chain containing the 
suitable hydrophobic and hydrophilic parts will be incorporated to promote aggregation.16   Thus, 
the quinone will serve as both the redox-sensitive grou
minohexanoic acid chain will be attached through a carbonyl group and will serve as the 




Figure 3.1 Structure of Q9. 
 The Q9 structure is amphiphilic and should aggregate in aqueous solution.  The quinone 
moiety serves as the redox, stimuli-responsive group in this structure.   In the presence of a 
reducing agent, Q9 is reduced to the corresponding hydroquinone, initiating the tri-methyl lock 
mechanism to facilitate the intramolecular cyclization/elimination event that breaks the backbone 
and 6-aminohexanoic acid (Figure 3.2).  Therefore, the disruption 
and un
of Q9 and liberates a lactone 





























Figure 3.2 Q9 reduction and intramolecular cyclization/elimination event. 
 
3.2       Synthesis Discussion 
The first part of this synthesis was to develop the tri-methyl lock quinone moiety, which 
was based on similar routes as those developed by Cohen and his coworkers.6-11  Lactone 2 was 
achieved via a 1,4- Michael addition of 3,3-dimethylacrylic acid to the trimethyl hydroquinone 1. 
e 2 lead to the 
roxysuccinimide (NHS) was coupled to the carboxylic acid of 3 to 
form th
Hydrolysis and subsequent NBS (N-bromosuccinimide) oxidation of lacton
formation of quinone 3. N-hyd
e NHS-substituted quinone 4 in order to later facilitate the linking of the aminohexanoic 



































Scheme 3.1 Synthetic scheme for the NHS-substituted quinone. 
The second part of this synthesis was to synthesize the chain structures, because even 
though several aminocarboxylic acid molecules with varying sized carbon chains are 
commercially available, they cannot be used due to their low solubility in organic solvent.  The 
tected 6-aminohexanoic acid 
chain s
e and coworkers.17 
C-MS and ESI-MS.  
The purity of products were determined by 1H NMR experiments.  Each peak in the 1H NMR 
spectra was integrated (solvent peak and TMS peak were not included), and the peaks from the 
following synthetic steps were conducted to develop a tert-butyl pro
tructure 7 to be added to the quinone moiety. 17 
The carboxylic acid group of the starting material CBZ- (carbobenzyloxy) protected 6-
aminohexanoic acid 5 was protected with a tert-butyl group to yield product 6. The CBZ moiety 
was subsequently removed using hydrogen gas and a palladium catalyst to obtain product 7 
(Scheme 3.2). This synthetic work was adopted from Le
Because NHS is a good leaving group, the chain structure 7 was easily attached to the 
synthesized quinone structure 4 to yield product 8.  Finally, the tert-butyl protecting group was 
removed from 8 using formic acid to achieve the final product 9 (Scheme 3.3). 




t were identified by their chemical shift position.  Proton peaks not associated with the 
product were also integrated & totaled to account for impurities.  The minimum purity of the 
product was calculated by the following formula: 
und minimum purity = (1- Total integrated non-product peak area/Total integrated 























Scheme 3.2 Synthetic route for the t-butyl protected 6-aminohexanoic acid (7). 
3.2.1    Synthesis of Lactone Product 2 
A round bottom flask (RBF) equipped with a stir bar and septum was used for this 
reaction.  Methanesulfonic acid (10 mL) was put into the RBF and heated to 70 ºC in a mineral 
oil bath.  Then, 6.6 mmol of the trimethylhydroquinone was added into the RBF, followed by 7.5 
mmol of the 3,3-dimethylacrylic acid. After stirring for 2 hours at 70 ºC, distilled water (125 mL) 
tate.  
ater, saturated NaHCO3, and NaCl solution, then dried 
by MgSO4.  The solvent was removed by rotary evaporation.  The product was dissolved into a 
was added and the dilute solution was then extracted three times with 50 mL of ethylace
The extracts were washed with distilled w
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CHCl3:hexane (30:70) solvent for recrystallization, and the solvent was finally removed under a 
high vacuum.  The overall process yielded 45% of the white powder lactone 2.  The 1H NMR 
spectrum was identical to that reported in literature 7 and was 99.1% pure based on the NMR 
integrated peak intensity calculation (Appendix 1.1).  GC-MS showed one dominant peak with a 
molecule weight of 234 g/mol (Figure 3.3), which corresponds to the lactone product.  
1H NMR (300 MHz, CDCl3) δ ppm:  2.55 (s, 2H), 2.36 (s, 3H), 2.22(s, 3H), 2.18(s, 3H), 
1.54(s, 3H), 1.45 (s, 3H) 
 
O
Spectrum 3.1 1H NMR spectrum of product 2. 
 
 





































Scheme 3.3 Synthetic route for the amphiphilic molecule Q9 with the quinone stimuli-
responsive group. 
3.2.2    Synthesis of Quinone Acid 3 
NBS was recrystallized three times from water. Lactone 2 (21 mmol) was dissolved in 
247 mL of CH3CN:H2O (1:9) in a 1.0 L RBF.  NBS (22.2 mmol) was dissolved in 49.5 mL 
acetonitrile and added to the RBF dropwise with constant stirring at room temperature (RT).  
After two hours, the contents were extracted three times with 150 mL of ether, followed by 
washing three times with both pure water and NaCl solution.  The ether was then removed by 
rotary evaporation.  The product was recrystallized from hexane and acetone.  White cube-
shaped crystals were obtained in 85% yield.  The structure was confirmed by 1H NMR which 
lished data.18  The purity of product 3 was calculated and found to be 98.8% agreed with the pub
(Appendix 1.2). 
1H NMR (300 MHz, CDCl3) δ ppm: 3.03 (s, 3H), 2.15 (s, 2H), 1.95 (s, 3H), 1.93 (s, 3H), 
1.44 (s, 6H) 
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de (NHS) were added to 
easing the temperature, and then the RBF 
was removed from the ice bath and reacted at room temperature for 20 hours.  The solution was 
filtered to remove any solid powder and dried using rotary evaporation to remove THF.  DCM 
(100 mL) was used twice to strip off THF dur g this process.  The product obtained was 
dissolved in 10 mL DCM, then passed through a silica column, which has been flushed prior 
solvent composed of DCM, hexane, and 
d was confirmed by the thin 
layer c
 
H NMR spectrum of quinone acid 3. 
3.2.3    Synthesis and Separation of NHS Substitute Quinone 4 
Quinone acid 3 (16 mmol) and 17 mmol of N-hydroxysuccinimi
a RBF kept at 0 ºC.  The mixture was stirred at 0 ºC, and 125 mL of THF was added.  DCC (19 
mmol) was added slowly into the solution to avoid incr
in
with DCM to remove any air bubbles.  A mixture of 
ether acetate was used to flush the column.  The product obtaine
hromatography (TLC).  The solvent was removed by rotary evaporation and kept under 















NMR spectrum matched the literature values,11  and the purity of product 4 was calculated to be 
95.1% (Appendix 1.3).  
1H NMR (300 MHz, CDCl3) δ ppm: 3.28 (s, 2H), 2.79 (s, 4H), 2.17 (s, 3H), 1.96 (s, 3H), 




esis of tert-butyl 6-(benzyloxycarbonylamino) Hexanoate 6 
N-benzyloxycarbonyl-6-aminohexanoic acid 5 was purchased from Novabiochem and 
used without further purification.  Ten mmol of 5 was dissolved in 30 mL DCM and introduced 
into a pressure-resistant bottle, which was cooled in a dry ice and acetone mixture.  Isobutylene 
(40 mmol) was cooled into a liquid state and poured into the bottle.  The contents in the bottle 
were stirred using a stirring bar.  To this, 96% sulfuric acid (0.2 mL) was added, and the 
pressure-resistant bottle was sealed and placed at room temperature for 48 hours.  After the 
lize the reaction and the 
 water three times.  
MgSO4
um 3.3 H NMR spectrum of the NHS substitute structure 4. 
3.2.4    Synth
reaction was stopped, a NaHCO3 solution (150 mL) was used to neutra
organic phase was collected and washed with NaCl solution and distilled
 was added to dry the organic phase, it was then filtered, and the solvent was removed 
under vacuum resulting in an oil-like product in 85% yield.  H NMR data confirmed product 
formation and GC-MS was used to analyze product 6, which showed a dominant peak whose 




product 6 and reactant 5 showed a tert-butyl group attached to the carboxylic acid side 
(Spectrum 3.4).  The purity of product 6 was calculated and found to be 98.6% (Appendix 1.4). 
H NMR (300 MHz, CDCl1 3) δ ppm: 7.40 (m, 5H), 5.13(s, 2H), 3.25 (m, 2H), 2.39 (m, 
2H), 1.69 (m, 2H), 1.59 (m, 2H), 1.43 (m, 2H) 
3.2.5    Synthesis of t-butyl Protected 6-aminohexanoic Acid 7 
Tert-butyl 6-(benzyloxycarbonylamino) hexanoate 6 (6.8 mmol) was dissolved in 10 mL 
of ethanol, and 10% palladium on carbon catalyst was added to the solution.  The solution was 
stirred under hydrogen atmosphere for 48 hours at ambient pressure. The catalyst was removed 
by filitration. Ethanol was removed by rotary evaporation and ethyl acetate (10 mL) was added 
three times to completely remove the solvent.  Finally, the product was put under high vacuum 
overnig
 compound 7 is 187 g/mol.  GC-MS data showed 
r weight.  1H NMR data also 
confirm
by nano-pure water two times.  
ht to obtain an oily product in 90% yield. GC-MS analysis was used for the 
characterization of 7.  The molecular weight of
one major peak with an integrated ratio > 90% of this molecula
ed formation of 7.  The reactant 6 and product 7 1H NMR spectra were compared in 
Spectrum 3.5, which clearly shows that the CBZ group has been removed after H2/Pd treatment.  
The product 7 was determined to be 98.3% pure (Appendix 1.5). 
1H NMR (300 MHz, CDCl3) δ ppm: 1.36 (m, 2H), 1.44 (s, 9H), 1.4-1.5 (m, 2H), 1.60 (m, 
2H), 1.65 (s, 2H), 2.21 (t, 2H), 2.67 (t, 2H) 
3.2.6    Synthesis of Molecule 8 
NHS-substituted quinone 4 (1.4 mmol) was dissolved in 20 mL of DCM in a RBF, 1.4 
mmol t-butyl protected 6-aminohexanoic acid 7 was then added to the above solution with 
stirring.  TEA (1.5 equivalents) was injected into the RBF while purging with nitrogen.  The 
reaction was stirred for 24 hours at room temperature, after which, the solution was washed three 
times using saturated NaHCO3 aqueous solution, and followed 
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The org
-like crystals were obtained, and a chromatography 
ls were obtained in 95% yield, 
and 1H
anic phase was collected and dried using MgSO4.  After filtering, DCM was removed by 
rotary evaporation.  The light yellow cube
column was used to purify the product. Yellow plate-shaped crysta
 NMR confirmed the structure.    The purity of product 8 was found to be 99.5% 
(Appendix 1.6). It was shown in Spectrum 3.6 the overlay of 3 and 7 will be similar to 8. 
1H NMR (300 MHz, CDCl3) δ ppm: 5.50 (s, 1H), 3.18 (m, 2H), 2.82 (s, 2H), 2.25 (m, 




                   
Spectrum 3.4 Comparison of 1H NMR spectra of reactant 5 and product 6. 
3.2.7    Removal of the Protecting Group in Compound 8 to Achieve the Final Product 9 
 
Compound 8 (50 mg) was dissolved in 20 mL of formic acid in a RBF and the bottle was 













removed by rotary evaporation.  Ethyl acetate (10 mL) was used three times to remove the 
formic acid completely.  
 
Figure 3.4 High resolution ESI-MS of product Q9. 
1H NMR confirmed the formation of compound 9 (Spectrum 3.8).  By comparing the 1H 
NMR spectrum of the target compound 9 with that of the starting material 8, it clearly showed 
that the t-butyl group had been removed. The 95% yield was achieved for this reaction.  The 
purity of product 9 was calculated to be 98.9% (Appendix 1.7). 
1H NMR (300 MHz, CDCl3) δ ppm: 5.50 (s, 1H), 3.18 (m, 2H), 2.82 (s, 2H), 2.25 (m, 
2H), 2.16 (s, 3H), 1.99 (m, 3H), 1.57 (s, 6H), 1.48 (m, 2H), 1.32 (m, 2H) 
ESI-MS (Figure 3.4): m/z found for 9 is 364.2113, with δ=-1.5096 ppm. 
 
 









































Spectrum 3.6 (a) Proton-labeled molecule 7, 3 and 8 (b) Comparison of 1H NMR spectra of 
product 8, 3 and 7. 
 
 
Spectrum 3.7 Labeled 1H NMR of final product 9. 
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CHAPTER 4. PROPERTIES OF THE NOVEL SURFACTANT Q9 
 
4.1       The pH Sensitivity of Q9 Molecule 
ntermediate pH range was found to be suitable for the development of these 
e of the Q9 surfactant and fatty acids, this pH range was expected to apply for 
H values, particularly at high pH (pH>10).   Thus, it was 
rpose of studying stability, Q9 solutions were prepared in phosphate buffered 
ution color 
the pH was raised above 10.5, which indicated that the Q9 
alues 
d 9.0 for long periods of time (on the order of a week), as noted by the persistent 
 in vary basic (pH = 11 and 14) and the intermediate pH values 
4.1.  
here are significant differences in the UV-vis absorbance signals of the samples. The Q9 
 in PBS possess one major peak around 267 nm, 
 
0 nm.  This 
ed, 
hat high pH values result in appearance of this peak. These differences indicate that 
me structures changes occur when Q9 was dissolved in a strong base solution.  The detail of 
Previous studies have confirmed that the formation of fatty acid surfactant vesicles is pH 
sensitive.1-3  An i
types of vesicles, which usually ranged from 7.0 to 9.0.  Because of the similarity in the 
molecular structur
successful Q9 vesicle formation.  However, it is important to note that quinones have been 
shown to be affected by extreme p 4-6
necessary to explore the stability of Q9 at various pH values. 
For the pu
saline solutions (PBS, 0.1 M) with a pH value that ranged from 7 to 11.  The sol
changed from yellow to red when 
molecule underwent some changes in the strong base environment.  Q9 was stable at pH v
between 7.0 an
yellow color. 
The Q9 samples prepared
were analyzed by UV-vis spectroscopy.  The experimental results are displayed in Figure 
T
samples prepared at pH 7.0 and at pH 10.2
which is typical of quinone molecule in aqueous solution.  However, the Q9 sample prepared in
pH 11 PBS has a measurable difference, with a new “broad” peak around 47




the Q9 struc dy, but it is 
sed similarly to other quinones.  However, the UV-
vis stud
tural change under the different pH environment is not related to this stu
assumed that the quinone moiety is decompo
ies showed that the Q9 structure is unaffected under weakly basic environments (7 < pH 
< 10) for periods of up to seven days. 
 
Figure 4.1   UV-vis spectra of Q9 samples prepared in 0.1M pH 7.0 PBS, 0.1M pH 10.2 
PBS, 0.1 M pH 11 PBS, 0.1 M pH 14 NaOH and PBS solution. 
 
1H NMR experiments were conducted on Q9 samples which were prepared at different 
pH values.  It was discovered that the Q9 samples prepared in the pH range of 7.0 to 9.0 retained 
their characteristic spectra features, as noted by comparing the NMR spectra of Q9 in CDCl  








Figure 4.2 H NMR spectra (300 MHz) of 8 mM Q9 in pD 8.0 D1
 of n-alkanoic acids to form vesicles under such solution conditions, pH 7.8 PBS 
2O (NaD2PO4) immediately 
(a) and 72 hours (b) after sample preparations. 
 
Because of the observed stability of the Q9 structure between 7.0≤pH≤10.5 and the 
known ability
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was selected as the solution in which Q9 properties were to be examined unless otherwise stated. 
It was assumed that at pH 7.8 solution conditions would lead to roughly equal amounts of 
deprotonated and protonated carboxylic acid groups in Q9.1, 3 
4.2       Redox Stimuli-responsive Property of Q9 
The purpose of this project was to use a novel surfactant Q9, which was possible be 
controlled by redox stimulation, to develop new redox stimuli-responsive vesicles.  In previous 
synthetic steps, Q9 was synthesized successfully with the designed structure (Chapter 3).  In the 
following studies, the potential redox stimuli-responsive mechanism and the surfactant 
aggregation properties of Q9 will be examined. 
4.2.1    Confirmation of the Cleavage of Q9 Structure Upon Redox Stimulation 
Q9 possesses a tri-methyl lock quinone moiety, which should be easily reduced by a 
chemical reducing agent.7, 8  The reduction product, a hydroquinone, has the potential to undergo 
a spontaneously intramolecular cyclization/elimination reaction.  This lactonization reaction 
should result in the cleavage elimination of the amino-carboxylic acid backbone of Q9, as well as 
the loss of its amphiphilic property for aggregation. This is outlined in Figure 4.3. 
Sodium dithionite, Na2S2O4, has been used as an efficient reducing agent in many redox 
reaction studies in aqueous environment, including tri-methyl lock molecules similar in structure 
to Q9.9, 10  Thus, I have chosen it as the reducing agent to trigger the reduction reaction and drive 
the cyclization/elimination lactonization of the Q9 molecule. 
1H NMR analysis was used to probe solutions of Q9 exposed to S2O42-. Upon S2O42- 
cyclization/elimination process. Two fragment products should be generated: one being the 
hydroquinone lactone product, and the other being 6-aminohexanoic acid from the Q9 chain.  
The lactone is known to be insoluble in water and will form a precipitate.  It was found that 
addition, the quinone of Q9 should be converted to the hydroquinone to allow for the 
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proton signal of the lactone was not detected by 1H NMR upon completion of the reaction, 
consistent with its insolubility (Figure 4.5).  However, the 6-aminohexanoic acid remained 
soluble, and it was stable in the aqueous phase as noted by the proton signals of 6-
mpared to the stable 1H NMR signal of the 
6-amin
aminohexanoic acid after the reduction reaction.  Co
ohexanoic acid chain, the decreasing 1H NMR signal of the quinone moiety can be used 



























he progress of 
the Q9
e and in the original Q9 molecule.  
The int
 
Figure 4.3 Proposed cleavage of Q9 structure triggered by reducing agent. 
Two protons, denoted as e and a (Figure 4.4), were chosen for monitoring t
 destruction process. Proton e belongs to the quinone moiety, and due to the insoluble 
lactone structure, its intensity should decrease with time as is observed in Figure 4.5.  Proton a 
belongs to the chain structure and is presented in both the  
6-aminohexanoic acid molecule product after the Q9 cleavag
















Figure 4.4 Location of proton e and a in the reactant and products. 
e
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1H NMR experiments were set up to observe the intramolecular cyclization/elimination 
process.  Q9 (2 mM) was dissolved at pD 7.8 D2O and placed in the NMR tube.  Five equivalents 
of Na2S2O4 were added to this tube to trigger the reduction reaction and the corresponding 
lactonization reaction.  The first 1H NMR acquisition was run 3 minutes after addition of 
Na2S2O4.  The second one was run 300 minutes later. Experiment results are shown in Figure 4.5. 
Signal a maintained the same peak intensity after the Na2S2O4 addition for the entire time 
of the experiment (300 mins).  Proton signal e was observed 3 mins after addition of Na2S2O4, 
but peak e is virtually undetectable after 300 minutes.  Three minutes later after the addition of 
Na2S2O4, the reduction reaction occurred and the hydroquinone formed from this reduction.  At 
that moment, the intramolecular cyclization/elimination lactonization reaction had not reached 
completion, and the hydroquinone was still dissolved in solution, proven by the observation of 
peak e in Figure 4.5.  During the 300 minute experiment, which was counted from the addition of 
sodium dithionite, the intramolecular cyclization/elimination lactonization reaction went to 
e proton e signal 
disappe
om the quinone moiety decreased to 
4.2.2    Kinetic Study of Lactonization Reaction 
The redox-responsive mechanism was confirmed by using 1H NMR to monitor the 
selected proton signals.  Using the same strategy, the kinetic process of the lactonization reaction 
was studied by 1H NMR experiments. 
completion. The lactone product precipitated from the solution, resulting in th
arance from the spectra. These results confirm that the desired Q9 redox response can be 
achieved in aqueous media with Na2S2O4. 
There is one thing that needs to be pointed out: not only do proton e and a experienced 
these changes, but the intensities of all proton signals fr
almost zero after 300 mins, while all proton signals from the aminohexanoic acid moiety in Q9 




Figure 4.5 H NMR spectra after Na2S2O4 addition at 3 and 300 mins. 
The intensity changes of proton signals e and a were selected again as the index for the 
lactonization reaction (Figure 4.6).  As shown in section 4.2.1, when Q9 is reduced to the 
corresponding hydroquinone structure, the tri-methyl lock mechanism causes the lactonization 
reaction.  The lactone product precipitates from solution, resulting in the decrease of proton e 
intensity, which can be used to determine the rate of the lactonization reaction. 
In order to study the kinetic process of the lactonization reaction, twenty three individual 
H NMR experiments were acquired over a 300 mins time period after the addition of the 
reducing agent (Na2S2O4).  Each experiment was undertaken with a time gap scaled from 21 to 
32 mins.  After the experiments, each of the 23 spectra was integrated to calculate the relative 
area of peak e and a (Table 4.1).  The relative area of peak a (from aminohexanoic acid chain 
structure) was used as the standard to normalize the corresponding relative area of peak e in each 
spectrum because its intensity is stable.  The natural log of the relative area ratio, Ie(t)/Ie(t=0), was 
plotted versus time.  The results are shown in Figure 4.7. 
3 minutes after the Na2S2O4 
300 minutes after the 









Figure 4.6 Spectrum of Q9 and 1H NMR assignments. 
A linear relationship (correlation coefficient r=0.997) was observed between ln(Ie(t)/I(t=0)) 





















  = -kt    
with I
⎟⎜ )(I te
reaction kinetic theory.  The rate constant can be calculated from the slope of the line: k = - 0.01 
e(t) being the relative peak area of peak e at time t; I(t=0) being the relative peak area of peak 
e before the redox reaction; Me the concentration of the product; M0 the initial concentration of 
Q9. 
The above equation is the integrated rate law for a first-order reaction based on chemical 
min-1.  From the first-order reaction law, the half-life time of the reaction can be calculated as 
follows: 
ln (0.500) = - kt1/2                                      
t1/2 = ln (0.500) / -k 
t1/2 = 69.3 min 
Table 4.1 Integrated 1H NMR signals for peak e and peak a of Q9 as a function of time 
after addition of Na2S2O4 to 5 mM Q9 in pD 7.8 D2O. 
 
Ia Ie Ie(normalized) Ie(t)/Ie(t=0) ln(Ie(t)/Ie(t=0)) Time(mins) 
1.000 0.960 0.960 1.000 0.000 0.000 
0.983 0.760 0.773 0.805 -0.217 22.000 
0.982 0.604 0.615 0.641 -0.445 43.000 
0.968 0.471 0.487 0.507 -0.680 64.000 
0.955 0.368 0.385 -0.913 85.000 0.401 
0.960 0.281 0.293 0.305 -1.188 111.000 
0.972 0.219 0.225 0.235 -1.450 138.000 
0.963 0.161 0.167 0.174 -1.748 164.000 
0.977 0.127 0.130 0.135 -2.000 195.000 
0.971 0.098 0.105 -2.256 227.000 0.101 
0.952 0.069 0.073 0.076 -2.584 258.000 




Figure 4.7 NMR kinetic experiments from 5 mM Q9 in pD 7.8 D2O exposed to solid sodium 
dithionite. 
 
Compared with other known tri-methyl lock quinone redox systems,8 this half-life time is 
suitable for the application.  As shown in Figure 4.2, there are two reactions that occur after the 
addition of Na   The fir tion is the  
Q9, which occurs virtually instantaneously as from UV-vis experiments on Q9 with added 
Na inimum tim
experiment after Na2S2O4 addition).  This can also be easily observed by eye, as the quinone 
form of Q9 is yellow, and the hydroquinone is colorless. The fast speed of this reaction and the 
virtu ntica
rea y NM
4.3       Critical Aggregation Concentration Study 
From a structural point-of-view, Q9 should possess the properties of a typical 
amphiphilic molecule that has the ability to aggregate in aqueous phase if its concentration is 
high enough.  To enable the formation of Q9 vesicles, it is important to find out at what 
2S2O4. st reac  formation of hydroquinone upon the reduction of
noted 
2S2O4 in Figure 4.8 (ten seconds were the m e for conducting the UV-vis 
ally ide l 1H NMR spectrum of the hydroquinone of Q9 makes it ignored to follow this 
ction b R. 
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concentration Q9 begins to form aggregates.  There are different methods that can be employed 
 determine the critical aggregation concentration (CAC) as noted by numerous previous 
studies.  In this study, tensiometry was selected for this purpose.11  The experimental details were 
described in Chapter 2.  In Figure 4.9, the CAC of Q9 was obtained from the surface tension 
detection method in pH 7.8 PBS (40 mM).  
to
 
Figure 4.8 UV-vis absorbance change after Na S O  addition of Q9 pH 7.8 PBS solution 
 
To compare these results, surface tension measurements were conducted on  
6-aminohexanoic acid, NH
2 2 4
  Two linear relationships were found from the experimental data.  In the low 
ecline that represented the surface tension 
2(CH2)5COOH, that under same solution conditions as Q9 in Figure 
4.9.  Experiment results are plotted in Figure 4.10. 
Q9 surface tension experimental results (Figure 4.9) were a good match with surfactant 
aggregation theory.
concentration range (from 0 to 7 mM), there was a d
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was de
ing for concentration, yielding a value of 7.1 mM. 
creasing with increasing Q9 concentration.  However, in the high concentration range (> 
roughly 7mM), another linear relationship was observed.  The slope was significantly less, 
presumably because no more Q9 molecules could insert into the monolayer at the air-water 
interface.  It is unclear at this time why the slope of the line is not zero at Q9 concentration above 
~7 mM; however, this is typical of many types of surfactants.  The intersection point of these 
two lines is the turn over point where Q9 aggregates are formed, with the concentration at this 
point being the CAC of Q9.  Thus, the determination of the CAC can be found by setting the two 
linear equations equal to each other and solv


























Figure 4.9 Surface tension measurements of Q9 in 40 mM pH 7.8 PBS solution as a 
function of Q9 concentration. 
 
As we look at the surface tension experiment of the 6-aminohexanoic acid (Figure 4.10), 
there is no change in the surface tension as its concentration was increased.  The surface tension 
as found to vary between 74 mN/m and 76 mN/m even though the concentration was increased 
above 50 mM.  Based on these results, 6-aminohexanoic acid is not an amphiphilic (surfactant) 
species, and it can not concentrate at the water-air interface when it is dissolved in aqueous 
w
 61
solution.  Thus, the surface tension will not be significantly affected upon the addition of the 
compound to aqueous solutions.  





























Figure 4.10 Surface tension measurements on 6-aminohexanoic acid in 40 mM pH 7.8 PBS 
solution. 
 
The different surface tension experimental results between 6-aminohexanoic acid 
molecule and Q9 confirmed the amphiphilic property of Q9.  Meanwhile, based on previous 
studies, 6-aminohexanoic acid was the only water-soluble structure present after the 
intramolecular ring cyclization reaction of Q9.  The surface tension property of this compound 
indicated that no aggregates will be formed after the redox reaction has reached completion at its 
concentration used (maximum concentration of 6-aminohexanoic acid would be ~ 10 m ). 
cid.  I
M
Micelles and planar bilayer aggregates can both be formed in solution from n-alkanoic 
a t is difficult to determine what type of aggregate was formed from Q9 at this point, but 
previous studies indicated that the single-chain surfactant vesicle formation concentration is 
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much lower than the critical micelles concentration.2, 3  Thus, a Q9 solution with a concentration 
prepared above the CAC concentration should be sufficient for the vesicle formation. 
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CHAPTER 5. Q9 VESICLE FORMATION AND CHARACTERIZATION 
5.1       Formation of Q9 Vesicles by Extrusion Treatment 
Q9 vesicles were formed by the extrusion technique, which has been extensively 
loy pholipid vesicle formation.1  This operation utilizes a device called an 
rough a membrane that is located inside the extruder.  The shear force has been proposed to 
chanistic details of vesicle formation 
his method has confirmed 
s efficacy for vesicle formation.  
 
as dissolved in 5 mL DCM in a round bottom flask and dried by rotatory evaporation to form a 
CM left 
side the flask; (2) 0.7 mL PBS solution (pH 7.8, 50 mM with 50 mM NaCl) was added into the 
te Q9 for 1 hour;  (3) After vortexing for 15 minutes, the Q9 solution then 
th;  (4) 
hen extruded through a hand- held extrusion device (Avanti Polar Lipids, 
, 
n process was repeated 20.5 times. Then the solution was transferred into a 
.2       TEM Experiments on Q9 Vesicles With Stained Materials 
mple 
as deposited onto a carbon-coated copper grid.  The negative stain method was used to stain the 
 been used for the study of phospholipid vesicle 
rmation.4, 5  The experimental results are shown in Figure 5.1. 
emp ed for phos
extruder to generate a strong shear force on the surfactant molecule, when they are pushed 
th
help cause surfactants to form vesicles.  Although the me
during the extrusion event is still under investigation, the practice of t
1-3it
Four steps were employed for Q9 vesicle formation using this method:  (1) 3 mg of Q9
w
thin layer film.  Then it was placed under high vacuum for 2 hours to remove any D
in
flask to hydra
underwent a freeze-thaw process 7 cycles by using a dry ice/acetone and a warm-water ba
The liquid was t
Alabaster, AL) with 100-nm pore diameter polycarbonate membrane (Whatman, Maidstone
UK). The extrusio
clean glass container and stored until needed in dark under N2. 
5
TEM experiments were employed to study the formation of Q9 vesicles.  The Q9 sa
w




      
 




spherical-like structures which were observed in the TEM experiment.  The diameter of these 
These preliminary TEM results indicated that aggregates of Q9 exist in solutions 
prepared as described here.  Vesicles and micelles were two possible aggregates6 for these 
imaged structures ranged from 20 nm to 160 nm in the samples, with an average size distributed 
around 80 nm. As shown in previous work with n-alkanoic acid, micelles with diameters smaller 
than 10 nm have been observed for solution pH values of 8.5 to 12.7  Larger micelle aggregates 
have been reported, but generally these structures were resulted from the surfactants that 
contained high molecular weight polymer  
chains.8, 9  The edge area on the captured spherical aggregates in the TEM image was identical to 
a round spherical structure, which is the typical vesicle aggregate structure.  Thus, it is 
reasonable to conclude the aggregate structures observed in these TEM images are vesicles of Q9.  
5.3       Light Scattering Measurement on Q9 Vesicles Sample 
Light scattering techniques have been widely used for the characterization of particles in 
solution.10  Two different light scattering techniques were used to characterize the Q9 vesicles: 
static light scattering (SLS) to determine the radius of gyration (Rg), and dynamic light scattering 
(DLS) to determine the hydrodynamic radius (Rh).  
5.3.1    Light Scattering Experiments on a Home-Built Instrument 
Q9 vesicle samples prepared in variety PBS solutions (50 mM with 50 mM NaCl) were 
investigated by both SLS and DLS measurement.  The light scattering instrument is a home-built 
machine in Dr. Russo’s lab in the Department of Chemistry at LSU.  The experimental results 
are listed in the following Table 5.1. 
Samples 1 and 2 were prepared in pH 8 PBS with different Q9 concentrations.  Sample 3 
was extruded at pH 10.2 PBS.  Sample 4 is Q9 vesicle sample extruded at pH 11.6, then the pH 
was adjusted to 6.9.  
These results revealed some interesting properties about Q9 vesicles.  First of all, the 
ontainers had been treated carefully to remove any dust and impurities.  Thus, the aggregates 





1 2 3 4 
 can only be generated from the Q9 molecule.  Sample 1 failed in the observation of Rg 
because of the low quality decay line recorded during the experiment time.  The calculation of Rg 
is unavailable based on the collected data.  This may be caused by the wide distribution of 
particle sizes that exist in solution for this particular sample. 







12 mM Q9, 
11.6, then 
10 mM Q9, pH 12 mM Q9, pH 
 
12 mM Q9, pH prepared at pH 
adjust to pH 6.9
Rg (SLS) N/A 112 ± 1 nm 147 ± 1 nm 119 ± 1 nm 
R  (DLS) 140 nm  132 nm 
 
71.4 nm 61.6 nm h  & 39 nm 
 
&  24 nm 
 
Different Rh sizes are formed at different pH value.  Q9 samples prepared at pH 8.0 
(samples 1 and 2) possess an 
S (112 nm, 147 nm, 119 nm) do not exhibit this significant 
size ch
ple 4 are much bigger than 1, which indicates the difference of those 
Rh value that is obviously larger than the Rh of Q9 samples prepared 
under a higher pH value (samples 3 and 4).  Even for sample 4 where the pH had been decreased 
to 6.9 after Q9 vesicle formation, the Rh was still much smaller than samples prepared directly at 
pH 8.  The Rg sizes obtained from SL
ange in different pH PBS solution.  Based on the LS theory, the Rg vs Rh ratio of the 
perfect hollow spherical structure equals to 1.0. Except for sample 2 (pH 8), the ratio of Rg vs Rh 
in sample 3 and sam
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aggrega
. samples 1 and 2): one larger size 
ehavior for Q9 in aqueous buffer solutions.  Extrusion of phospholipids typically leads to 
 a narrow-sized distribution of vesicles.13  The presence of two populations of Q9 
ay be contributed by the special quinone group in the molecule, as well as the result of 
the decreased bilayer stability of Q9 ecause of its single-chain structure
r Nano Ins
The DLS experiments were conducted using a Malvern Zetasizer Nano Instrument 
Worces re, UK).  Tw samp sen for this experiment.  One 
was a traditional phospholipid vesicle, dioleoylphosphatidylcholine (DOPC), in water solution, 
own to ble vesicles upon extrusion.  The other was Q9 vesicle prepared in pH 
7.8 PBS (50 mM) solution under condition identical to sample 2 in Table 5.1.  Both samples 
ere developed through the same procedure obtained in Section 5.1.  
tes from a hollow spherical structure. One possible reason for these results may come 
from the different protonation situation of the carboxylic acid group inside the Q9 structures 
under different pH.  The change of ratio between COOH and COO- groups from Q9 structure 
under high pH value would affect the vesicles’ structure.11, 12   
Dynamic light scattering has the advantage of measuring smaller sized particles 
compared with SLS experiments.10  Each DLS experiment on pH 8.0 samples led to observation 
of two different size distributions existing in the samples (i.e





trument 5.3.2    Dynamic Light Scattering Experiment on Zetasize
(Malvern, tershi o different les were cho
which is kn  form sta
w
DOPC was used as a model lipid compound to generate vesicles.  DOPC vesicle 
formation is well documented in previous studies, including those that employ the extrusion 
technique.14, 15  Therefore, it was used as a standard for comparison to Q9 vesicles.  The 




Figure 5.2 DLS experimental results for DOPC vesicle sample (1 mg/mL DOPC in 50 mM 
 
pH 7.8 PBS). 
Both DOPC and Q9 samples yielded the particle size distribution peaks based on the 
scattering intensity measurement, confirming the formation of aggregates in these samples.  The 
DOPC data possesses a sharp, narrow peak centered near 120 nm in Figure 5.2.  This was in 
qualitative agreement with previous reports on DOPC vesicles.1  The Q9 aggregates had a 
broader distribution range than DOPC (Figure 5.3).  Two peaks were observed for this sample.  
The major peak is located at 160 nm (diameter), and there is also a smaller peak intensity 
centered at near 40 nm diameter.  Because of the overlap of this 40-nm peak with the major peak 
at 160 nm, the data appears a shoulder style in the Figure 5.3.  Compared to the DOPC sample, 
we can conclude that there were two different size distributions in the Q9 samples. 
The mechanism of the extrusion process is still under investigation;1  however, it is 
believed the pressure generated inside the membrane hole reorganizes the aggregates and helps 
form them into spherical vesicles.2  For the work here with DOPC, the membrane pores clearly 
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restricted the size of vesicles when they were formed.  Q9 is a single-chain surfactant structure 
possessing a carboxylic acid group; the stability of the bilayer structures formed from this 
molecule are evidently more difficult to control compared with the two tailed phospholipid 
DOPC. Thus, a wide distribution of aggregates was generated during the extrusion process. 
 
Figure 5.3 DLS experimental results for Q9 vesicle sample (12 mM Q9 in 50 mM pH 7.8 
PBS). 
 
5.4       CryoEM Experiment on Q9 Vesicles 
CryoEM was used to characterize vesicle size and to obtain possible information on 
lamellarity of the Q9 structures. As has been previously shown, CryoEM can be used to obtain 
the closest version of the solution structure of aggregates.  The vesicle solution samples were 
frozen quickly into a thin ice film on TEM grids.  The frozen vesicle sample in this process is 
believed to have the least possible distortion and contain the fewest possible artifacts.
16
16  Q9 
vesicle samples were prepared through the extrusion technique in pH 7.8 PBS (50 mM) solution 




The CyroEM images not only confirmed the formation of Q9 vesicles upon extrusion of 
12 mM Q9 in pH 7.8 PBS, but vesicle’ size information can be obtained.  From the images, the 
Q9 vesicles possess widely different sizes, ranging from 20 to 150 nm.  The concentration of 
these vesicle aggregates were not high enough to make them homogeneously observed on the 
TEM grid.  The dynamic fatty acid vesicle formation model can be utilized to describe Q9 
vesicle samples17 (See Figure 1.7 in Chapter 1).  The Q9 vesicles may be dynamic balance 
system constructed by the small number vesicles surrounded by many Q9 single molecules and 
small Q9 micelles, which has been described by other fatty aid aggregates studies. 17 Based on 
this theory, it will be difficult to achieve highly concentrated Q9 vesicles in the extruded samples.  
5.5   Study of Q9 Vesicle Distribution by Asymmetrical Flow Field-Flow Fractionation 
(AF4) Technology 
 
AF4 technology was applied to study the size distribution of extruded Q9.18-20  DOPC 
vesicle samples that were made using the same extrusion technique were used as a standard 
sample to develop suitable experiment methods for control of the field flow.18  The light 
scattering intensity was used to monitor the eluted samples.  After the experiment, Rg of the 
particles was calculated using the instr software as a function of elution time.  
Experimental results are shown in Figure 5.5 and Figure 5.6.    
Comparing the experiment results of 1 mg/mL DOPC sample and 4.5 mg/mL Q9 sample 
s than 2% of the light scattering intensity of eluted DOPC vesicle sample, which indicated 
 the sample.  The high CAC value of 7.1 mM (by 
surface
ument 
prepared under the same condition, the recorded light scattering intensity of eluted Q9 aggregates 
as lesw
a much lower concentration of Q9 aggregates in
 tension measurement, Chapter 4) would indicate that Q9 does not prefer to exist in the 
aggregates. Although the Q9 samples were prepared above its CAC, it was difficult to form a 
high concentration of Q9 aggregates.  The effort to increase Q9 aggregate number by increasing 





Figure 5.4 Q9 vesicles developed by extrusion treatment with a variety of sizes. 
 
Experiments were conducted under conditions described in Section 2.3.4 in Chapter 2. 
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Figure 5.5 Light scattering intensity (recorded at 90o) of 12 mM Q9 sample in pH 7.8 PBS 
(50 mM) during the AF4 separation process; peak at 9 min and 70 min are generated by 
the flow condition change. 
 
 
Figure 5.6 Rg size distribution calculated from AF4 experiment on Q9 sample. The data 
value changed after 50 minutes due to the change of flow condition. 
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Although the concentration was low, AF4 experiments confirmed the existence of Q9 
aggregates with different sizes and provided a size distribution (Figure 5.6).  In this experiment, 
different field-flow conditions were applied to achieve the best separation.  Nine minutes after 
the sample injection the flow condition was maintained to separate the vesicles with different 
sizes.  Fifty minutes later, the flow condition was adjusted to flush the larger particles out.  A 
main elution peak around 47 min can be observed, as well as a small peak around 30 min.  The 
calculated particle sizes (Rg value) for the corresponding peaks were 110 nm (45 min) and 40 nm 
(30 min).  Furthermore, there were different sizes that ranged from 20 nm to 220 nm that eluted 
at different times.  These different-sized aggregates are difficult to be classified as micelles, 
because one compound usually only forms one uniform micelle structure in a given solvent 
.6       Conclusion from Different Characterization Methods 
Through each of the characterization methods, Q9 aggregate formation was confirmed.  
Light scattering results from the home-built machine (Russo Lab, Chemistry Department, LSU) 
and Zetasizer Nano Instrument (Malvern, Worcestershire, UK) both point to the existence of Q9 
aggregates having different sizes.  These particles had a wide size distribution that ranged from 
20 nm to 200+ nm.  Also, DLS data led to observation of two major sizes for these particles.  
CryoEM images of Q9 aggregates in buffer solution point to a similar outcome, as different 
particle sizes were found and spanned the 20-200 nm range.  These aggregates are believed to 
best represent the original structures in buffer solution because of the inherent properties of 
istribution of Q9 vesicles was observed.  These results confirmed the previous DLS and 
CryoEM results. 
system.21  Vesicle morphology was the suitable model to explain these aggregates type.   
5
CryoEM.  The typical spherical structure and large size of these Q9 aggregates from these 
experiment results confirmed them to be vesicles.  From the AF4 separation study, the size 
d
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Although Q9 vesicle formation was confirmed through these characterization methods, 
both CryoEM and AF4 separation indicate that the concentration of Q9 vesicles is low in the 
aqueous buffer solution used here.  One reasonable explanation is coming from the structure of 
the single hydrocarbon chain Q9 molecule, which is difficult to get stabilized as those “double 
tail” phospholipids, when Q9 vesicles are formed.  The whole solution system may be 
constructed by Q9 vesicles surrounded by many Q9 molecules, which was similar to the other 
single chain fatty acid vesicle systems.17 
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     CHAPTER 6. STUDY OF THE ENCAPSULATION AND CONTROLLABLE 
RELEASE PROPERTIES OF Q9 VESICLES 
 
ctonization reaction of Q9, and these experimental outcomes point to the distinct possibility 
ox stimulation may allow for control over the confinement of guests within the aqueous 
n 




he extrusion technique as outlined in Chapter 5.  
mple cells, sample 1 and 
mple 2.  Sample 1 was used as the Q9 vesicle background.  Solid Na2S2O4 40 mg (10 
as performed on both 
le
Clearly, the addition of Na2S2O4 changed the nature of the Q9 vesicles in solution.  The 
tensity containing some quite large particles (> 200 nm).  This indicated that most of the 
LS is based on the measurement of particle diffusion coefficient (D), which makes it sensitive 
e Q9 reduction reaction: the hydroquinone lactone and the 6-aminohexanoic acid (Chapter 4).   
 
In Chapter 4, sodium dithionite, Na2S2O4, was used to successfully trigger the
la
that red
interior of Q9 vesicles. Thus, it is anticipated that the ring cyclization lactonization reactio
sh
encapsulation and possible controllable release properties of Q9 vesicles will be evaluated in 
C
6.1       DLS Experiments on Q9 Vesicles  
A Nano-Zeta DLS instrument (Malvern, Worcestershire, UK) was utilized for this
research. Q9 vesicle samples were prepared via t
The Q9 solutions prior to extrusion were made at 12 mM Q9 concentration in 50 mM pH 7.8 
PBS solution. Two Q9 vesicle solutions were placed in the DLS sa
sa
equivalents) was added to sample 2 and mixed for 5 minutes.  Then DLS w
samp s.   Results are shown in the Figure 6.1. 
original Q9 aggregate peak was diminished after the treatment, leaving a broad peak with low 
in
original Q9 vesicles were spontaneously altered (much smaller size) by the reduction reaction.   
D
for the detection of small particles due to their higher D value.1  Two products are formed from 
th
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It would appear that lactone particles formed in the solution precipitated out with a random size 





Figure 6.1 DLS experiment on the redox-stimulation results (a) 12 mM Q9 vesicle sample 
icle sample in 50 mM pH 7.8 PBS after Na2S2O4 
treatment. 
 
Filtered (membrane pore size 100 nm) 12 mM 6-aminohexanoic acid buffer solutions 
were examined under the same LS experiment setup, which theoretically should have no 
in 50 mM pH 7.8 PBS (b) 12 mM Q9 ves
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particles present, due to its good solubility in water.  However, there were always non-repeatable 
peaks showing up in the experiment results, which indicated the peaks shown in those results can 
not represent the real particles inside the solution. Those peaks were similar to the peak around 1 
nm in the previously sample 2 experiment (Figure 6.1b) in Q9 vesicle reduction.  Based on this 
control experiment, the small particle peak (around 1 nm) in Figure 6.1b is considered an artifact 
in the r
                     
esults, and most likely resulted from software limitations. 
DLS experiments were also conducted to monitor the change of particle’s sizes of 12 mM 
Q9 vesicle sample after the reduction reaction triggered. Experiment was set up as the same as 
those described in the first paragraph of 6.1. Each experiment was run every one minute after the 
addition of 10 equivalents of Na2S2O4 (beginning at 3 minute). The results are shown in Figure 
6.2. 
 
Figure 6.2 Particle’s sizes of 12 mM Q9 vesicle sample in 50 mM PBS monitored by DLS 
after Na2S2O4 addition. 
 
The initial Q9 vesicle possesses a diameter of 140 nm in this sample. After the reducing 
agent addition, the particle size increased dramatically with a random size distribution, which 
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indicated the formation of lactone solid particles upon the reduction reaction. About thirty 
minutes later, the particle size began to decrease into the size range below 1000 nm, which can 
be explained by the precipitation of lactone particles onto the bottom of solution. 
6.2       Encapsulation of Water-Soluble Calcein Dye in Q9 Vesicles 
The encapsulation characteristics of Q9 vesicles and their reduction induced release 
properties were investigated using calcein dye, and were followed with fluorescence intensity 
measurements.  Calcein is widely used as an encapsulation agent in vesicle-related studies.2-4  
Upon excitation at 495 nm, a strong emission is monitoring at 510 nm for dilute solution of 
ein.  The self-quenching property of calcein has been reported in previous work,5  with 
iffere
aCl, pH 7.8).  Q9 (12 mM) was 
dissolv
calc
efficient self-quenching occurring when calcein concentrations were higher than 10 mM, leading 
to a significant loss in fluorescence intensity with increased calcein concentration.5  Thus, the 
d nce in fluorescence intensity between quenched and free calcein can be used to monitor its 
encapsulation and release status in vesicle encapsulation studies.  This effect can also be watched 
by eye, as different colors were observed for different concentrations of calcein, with 
concentrated self-quenching calcein solutions being red in color, low concentration non-
quenching samples being green.  This color difference was utilized to facilitate the collection of 
size-exclusion separation of vesicles. 
 Based on self-quenching property of calcein, highly concentrated calcein (50 mM) 
solution were prepared in PBS solution (100 mM with 100 mM N
ed in this concentrated calcein solution, then the solution was extruded as the same Q9 
vesicles preparation method as those described in Chapter 5.  Thus, calcein was encapsulated 
during the Q9 vesicle formation.  Free calcein molecules left in solution were removed by size-
exclusion chromatography as described below. 
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The characteristic of preparative size-exclusion chromatography were described in 
Chapter 2.6  When calcein was encapsulated inside the vesicles, the initial concentration of 50 
mM will be well maintained upon vesicle dilution/separation due to the protective of the vesicles 
nature.  Thus, the calcein inside the vesicle will stay self-quenched during the chromatography 
process and will be red in color.  However, free calcein in solution will be diluted to be lower 
than the self-quenching concentration during the separation process and will be green in color.  
Red Q9 vesicles containing calcein will move faster in the column based on the principle of size-
exclusion chromatography.  Thus, different colors should be observed in different parts of the 
column, as schematically shown in Figure 6.3, if the calcein has been encapsulated successfully. 
mental results were identical to that predicted above.  The observed red color at the 
uench
.  The UV-vis 
Q9 molecule absorbance 
intensi
Experi
leading edge of the separation can be explained only by the presence of encapsulated, self-
q ing calcein in the Q9 vesicles.  This result confirmed Q9 vesicles can be used to 
encapsulate water-soluble agents over the time scale of the separation process (60 min).  The red 
band was collected and the green aliquot was discarded.  The calcein containing vesicles were 
passed through another column to ensure all the free dye was removed.  Finally a UV-vis 
experiment was carried out on this sample to measure the absorbance intensity
experiment result was compared with the UV-vis experiment of the 
ty in the same buffer solution in the Figure 6.4. 
The recorded UV-vis absorbance peak for the column separated sample was located 
around 490 nm, which was identical to the calcein absorbance wavelength (Figure 6.4).  The 
pure Q9 molecule UV-vis absorbance intensity measurement in the same buffer solution shows 
no peak at 490 nm (Figure 6.4).  The sample was collected to exclude free dye, therefore, only 
big particles should be present in the sample.  The presence of small calcein molecule in this 




Figure 6.3 Illustration of the color change during the preparative size-exclusion 
chromatography separation. (a) mixed free calcein and vesicle samples with self-quenching 
concentration; (b) particles separated based on size. Q9 vesicles (large) containing calcein 
move faster through the column and diluted free calcein (small) moves slower. 
 
 
Figure 6.4 UV-vis absorbance experiment on the preparative size-exclusion 
absorbance experiment on 1 mM Q9 molecule in 100 mM pH 7.8 PBS. 






Green color moves slowly: 
(a) 
(b) 
Red color moves fast: 
Vesicles containing self-
quenching calcein 
Diluted free calcein below the  
self-quenching concentration 
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6.3       Study of the Controllable Release Property of Q9 Vesicles 
Q9 vesicles containing calcein from Section 6.2 were separated and collected in the 
buffer solution.  This sample was used to study the controlled release of dye from Q9 vesicles 
triggered by Na2S2O4 reducing agent. 
pH 7.8 PBS solution (100 mM with 100 mM NaCl,) was used to dilute the separated 
vesicle sample until the UV-vis absorbance intensity was within the range of 0.05 – 0.1.  This 
intensit
n emission wavelength of 
10 nm.  After a stable background was achieved, Na2S2O4 was added into the sample, and 
intensity measurements were recorded every 5 min.  The experiment results are shown in Figure 
6.5. 
The fluorescence signal of column-purified Q9 sample increased after the reducing agent 
was added.  The intensity changed immediately (47% intensity increase)  kept increasing 
(110% intensity increase) in the next 20 hours.  This result indicated the encapsulated calcein 
was released after the redox-stimulation occurred.  The fluorescence signal increased due to loss 
of the previous self-quenching state after calcein was released into the buffer solution.  This 
result confirmed the controllable release of calcein from Q9 vesicles can be achieved by the 
ncapsulation of calcein.5, 7, 8  In AF4 experiments, we found the concentration of these 
y range will allow the fluorescence study to be conducted within the instrument detection 
limits. 
The diluted Q9 sample was placed in the fluorescence sample cuvette and then put into 
the luminescence spectrometer (Perkin Elmer, LS50B, Waltham, MA).  A kinetic fluorescence 
mode was applied for this study.  Every 5 minutes a fluorescence intensity measurement was 




The increase in calcein intensity was not as large as that found in previous work with 
e
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aggregates (light scattering relative intensity) is obviously smaller than the traditional 
phosphilipid based liposome vesicles formed under the same conditions.  This was also 
confirmed by observations from the CryoEM experiments.  The decrease in number of 
aggregates will dramatically reduce the total volume available for calcein and result in lower 
fluorescence intensity than expected.  Meanwhile, AF4 experiment results showed small Q9 
aggregates are counted more than big ones.  The decrease in radius of a spherical structure will 
decrease its packing volume on a large scale (V~R3).  The more small vesicles present in the 
solution, the less the fluorescence intensity would change.  
 
Figure 6.5 Fluorescence intensity increases upon the addition of Na2S2O4 to Q9 vesicle 
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CHAPTER 7. SUMMARY OF CONCLUSIONS AND FUTURE STUDIES 
 
7.1       Summary of Conclusions 
 
Novel redox stimuli-responsive surfactant structure was synthesized successfully in seven 
steps.  1H NMR and MS were used to characterize the products.  The final product, Q9, was 
confirmed by ESI-MS and 1H NMR.  A “trimethyl-lock” quinone moiety was utilized in the Q9 
to enable the redox-stimuli responsive property.  Once the quinone moiety was reduced to the 
hydroquinone, a spontaneous intramolecular cyclization/elimination reaction occurred that broke 
the Q9 backbone.  This redox stimuli-responsive mechanism was confirmed by the 1H NMR 
kinetic study by monitoring the protons intensity change on the Q9 structure.  
Q9 is a typical amphiphile that can aggregate in an aqueous solution.  A critical 
aggregation concentration (CAC) of 7.1 mM for Q9 was obtained using surface tension 
measurement at room temperature.  Q9 structure is sensitive to the pH of the solution.  A UV-vis 
study on the Q9 solution samples prepared in different pH buffers found that a new absorbance 
peak near 470 nm appeared among the Q9 samples prepared in high pH PBS (pH>11).   1H NM  
sults confirmed that the structure stability of the Q9 was maintained in the intermediate pH 







was applied to observe the stability of the Q9 structure while the pH was varied.  Experimental 
re
range from 7.0 to 9.0.  Previous work found th
deprotonated fatty acid group in fatty acid molecules was achieved in this pH range, which was
suggested to be important for the formation of the fatty acid vesicle aggregates.  Thus, a pH 7
PBS was used as the solvent system to prepare the Q9 vesicles.  
The Q9 vesicle formation process was conducted by extrusion, which was used wi
develop phospholipids vesicles.  Q9 PBS solution (12 mM) above the CAC was chosen for th
extrusion to ensure aggregation would occur. After extrusion, CryoEM and Light Scattering
experiments were used to check the vesicle formation.  Both Static Light Scattering (SLS) and 
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Dynamic Light Scattering (DLS) confirmed the Q9 vesicle formation in the extruded sample.  
 
ryoEM experiments captured the direct image of these spherical Q9 vesicles.  The 
 the observation of these CryoEM images.   
gates 
e separated from the sample, which 
tche ing 
 vesicle sample than DOPC vesicle sample. Because AF4 separated the different sizes 
f particles, the size effect on the light scattering intensity should be eliminated. Thus, the 
bserved low intensity of light scattering signal can be inferred that there are less Q9 vesicles 
resent than the DOPC vesicle sample prepared under same conditions.   
Sodium dithionite (Na2S2O4) was used as the reducing agent to trigger the intramolecular 
yclization/elimination reaction, which can break the Q9 monomer.  Disassembly of Q9 vesicles 
as monitored by DLS. After the addition of 10 equivalents of sodium dithionite, Q9 vesicles 
ere destroyed based on the DLS experiment observation.  This result confirmed Q9 vesicles 
an be controlled by the designed redox stimuli-responsive mechanism. 
T esicles, 
lcein (50 mM), was chosen to be entrapped within the Q9 
esicle
fluorescence intensity increased after the Na2S2O4 addition, which indicated that the calcein 
DLS also detected that the sample was polydisperse with sizes ranging from 20 nm to 200+ nm. 
C
concentration of Q9 vesicle was small based on
Asymmetrical flow field-flow fractionation (AF4) was used to study the Q9 aggre
size distribution.  A variety of sizes of Q9 aggregates can b









o study the encapsulation and controllable release properties of the Q9 v
concentrated water soluble dye, ca
v s.  The encapsulation was conducted by the mixing of calcein and Q9 molecule together 
before extrusion.  After extrusion, vesicles containing calcein were separated from the free 
calcein by a preparative size-exclusion chromatography.  A fluorescence study was conducted on 
the Q9 vesicle/calcein sample without the interference from the free calcein molecule.  Sodium 
dithionite was added into this solution to trigger the release of calcein from the vesicle.  The 
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molecule was released after the redox-stimulation occurred.  The fluorescence signal increased 
due to loss of the previous self-quenching state after calcein was released into the buffer solution. 
This re
nted in this study demonstrated 
they 
sult confirmed that the Q9 molecules possess the ability to encapsulate a water soluble 
agent and to release it under the controllable redox stimulation.  
The fluorescence intensity increased in the controllable release experiment was not as 
large as that found in previous work with encapsulation of calcein.  This could be contributed by 
the low concentration of Q9 vesicles which generated by the extrusion method.  More studies 
were needed to be conducted in the future to improve the capacity ability of Q9 vesicles.  
However, the achievements in this study have confirmed Q9 vesicle system can be made by 
extrusion, and possesses the ability to encapsulate water soluble compound and release them 
under redox stimulation method. 
7.2       Future Work 
Q9 vesicles possess unique properties.  The work prese
can be controlled by the reducing chemical agent, sodium dithionite.  
 To adopt the Q9 vesicles into a variety of applications, a more comprehensive study is needed to 
explore the properties of Q9 under different environment. Other methods can be utilized to 
manipulate Q9, depending on the types of application desired. 
One potential application of Q9 vesicles is for the drug delivery system.  The toxicology 
studies of this molecule should be evaluated. Q9 has low toxicity to human based on the previous 
quinone based prodrug research.1-4  It is predicted the Q9 vesicle would meet the clinical 
standard when it is applied in vivo environment.  
The study in this dissertation exhibited the encapsulation and protecting mechanism of 
Q9 vesicles for the water soluble compound, which is crucial for the drug delivery system.  
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However, the reduction of the chemical compound sodium dithionite is difficult to apply in this 
kind of application.  Thus, a new stimuli-responsive mechanism should be used.  
It has been confirmed that some reductase enzymes have abnormal strong activities in the 
mutated cells.5  For example, DT-diaphorase (NADH:quinone) is an oxidoreductase enzyme 
widely 
in vivo application, the enzyme 
activity
exists in the cell membrane that can reduce quinone molecules.  Recent study on cancer 
cells found DT-diaphorase presented a super high activity compared with other enzymes in 
variety of cancer cells.  Although the mechanism of this strong enzyme activity is still under 
investigation, this property can be used to design the new stimuli-responsive mechanism for the 
Q9 vesicle delivery system. 
It was proven that the redox reaction of “trimethyl lock” quinone moiety in Q9 structure 
will cause the deterioration of Q9 molecule.  DT-diaphorase possesses a strong reduction ability 
that reduces the quinone molecule in the cell membrane.  This strong activity in the mutated cell 
will lead to the similar reduction of the Q9 structure. It is reasonable to adopt this ability onto the 
Q9 molecule to develop a new controllable release mechanism.  
Q9 vesicles containing water-soluble drug (developed by the extrusion technique) should 
be mixed with DT-diaphorase in vitro to study the drug release process.  The UV-vis detection 
method can be applied to monitor the change of the specific UV-vis adsorption peak of drug 
molecules during this process.  These changes indicate the drug compound can be released upon 
the breakage of the Q9 vesicles.  Different DT-diaphorase samples with a variety of activities can 
be achieved by adjusting the concentration and should be tested to find out the different response 
of the Q9 vesicles.  Due to the complex environment for the 
 will be different from their in vitro behavior.  Thus, more studies are needed with a 




Figure 7.1 Microfluidic channel with temperature gradient. 
Another application of the Q9 vesicle is to use them as the efficient containment and 
delivery system in the microfluidic analysis device, which can enable advances in “lab-on-a-
chip” technology.  The microdiameter channels inside these microfluidic devices cause the 
reagent to flow slowly and mix sluggishly compared to the regular flow condition.  Locascio and 
Vreeland, who specialize in this area at the National Institute of Standards and Technology 
(NIST), suggest that high efficiency mixing and reagent delivery is “fundamental important for 
the successful development and application of lab-on-a-chip devices”.6  Phospholipids vesicle 
aggregates have been employed for this kind of delivery application in microfluidic devices 
(Figure 7.1).  The release of the agent from these vesicles has been accomplished by a 
temperature gradient that is prebuilt in the channel.6  Results in this study showed that vesicles 
containing a small molecule can achieve high efficiency mixing and reagent delivery.  However, 
the temperature gradient vesicle breaking mechanism used in this system limited its application 
in many areas.  The increased temperature could not be applied to many samples including 
biological and chemical agents.  Furthermore, change of internal channel temperature will cause 
a different reaction kinetic process, which is difficult to monitor. 
The sizes of the developed Q9 vesicles ranged from 20 to 200+ nm.  They can move 
effortlessly inside these microsized channels.  The protective nature of these vesicles will help 
T0 Tm 
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transport agents in the channel safely.  Thus, both a target sample and an analysis agent can be 
contained and delivered with Q9 vesicles.  
 
of Q9 
To adopt the fatty alcohol stabilization method, chemical modification should be applied 
on the fatty alcohol structure.  A hydrophilic moiety should be attached on the fatty alcohols 
(C>11), to increase their water solubility at room temperature.  The new synthesized structure are 
hoped to be soluble in PBS solution and mix with Q9.  
The vesicles formation should be checked through CryoEM and AF4 experiment.  The 
impact of the chain length and the adding ratio of the new developed water soluble additives 
should be evaluated.  The controllable release property of this new vesicle should be monitored 
by water soluble dye encapsulation and release experiment.  The vesicle composed of two 
The packing efficiency of the Q9 vesicles needs to be enhanced for these applications to 
be successful. Two strategies can be adopted for this purpose.  One is to increase the Q9 vesicles 
number (vesicle concentration), and the other is to increase the size (diameter) of the Q9 vesicles. 
Either can enhance the encapsulation ability of Q9 vesicles.  
It has been pointed out, in this dissertation, that it was difficult to produce a large number 
vesicles through the extrusion treatment compared with the phospholipids vesicles 
prepared under the same conditions.  This indicated the difficulties on the stabilization of the Q9 
vesicles.  It has been reported that the addition of the fatty alcohol compounds inside the fatty 
acid vesicle solution would help to stabilize the vesicle aggregates.7  This method can be applied 
to increase the lifetime of Q9 vesicles.  Also, the size of Q9 vesicle would hopefully increase as 
the spherical structure became more stable.  The fatty alcohol that could be adopted for this 
purpose should possess a similar carbon chain length as the Q9 structure.   However, fatty 
alcohols with carbon chains greater that 11 are insoluble in aqueous solution, which make them 
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ents could perform differently from the pure Q9 vesicles in encapsulation ability.  The 
kinetic process of the breaking of this vesicle could be studied by NMR kinetic experiments and 
fluorescence method.  
After this work, it is predicted a suitable additive system can be selected.  Large 
quantities of vesicles will be produced with added stability due to this new water soluble additive, 
and bigger size vesicles are expected.  Thus, the enhanced packing capacity will finally allow 
these vesicles for more applications. 
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APPENDIX 1. PRODUCTS MINIMUM PURITY CALCULATION 
 Appendix 1.1 Product 2 
 
 
Non-product peaks intensity: 0.0090, 0.0043, 0.0059, 0.0192; 
Product 2 peaks intensity: 0.0397, 0.1669, 0.2439, 0.4716, 1.2554; 
Product 2 purity =  
1 - 
∑ ∑








Appendix 1.2 Product 3 
 
Non-product peaks intensity: 0.0036, 0.0086, 0.0133, 0.0004, 0.0159, 0.0408; 
Product 3 peaks intensity: 0.2589, 3.1937; 























195, 0.0182, 0.0388, 0.3716; 
.2643; 
4 purity =  1 - 
Non-product peaks intensity: 0.0307, 0.011, 0.0312, 0.0467, 0.




+ 0.3716) 0.0388, 0.0182, 0.195, 0.0467, 0.0312, 0.011, (0.0307,  7.2643) 0.9186, 2.0247, 1.7657, 1.9429, 0.6124,















tensity: 0.0119, 0.0086, 0.0464, 0.0516, 0.1185; 
Product 6 peaks intensity: 0.6693, 0.4489, 0.1562, 0.4273, 0.4445, 0.5464, 0.5587, 0.5225; 




+ 0.5225) 0.5587, 0.5464, 0.4445, 0.4273, 0.1562, 0.4489, (0.6693,  0.1185) 0.0516, 0.0464, 0.0086, ,






















Non-product peaks intensity: 0.0608, 0.0047, 0.0336, 0.3153, 0.2753, 0.2071, 0.7715, 1.6683; 
roduct 7 peaks intensity: 18.4234, 78.5656; 
 purity = 1 - Product 7
∑ ∑
∑
+ 1.6683) 0.7715, 0.2071, 0.2753, 0.3153, 0.0336, 0.0047, (0.0608,  78.5656) (18.4234,

















 peaks intensity: 0.1567, 0.3603, 0.3448, 0.394, 0.5301, 1.07146, 2. 7314, 3.0201, 
.3847; 
roduct 8 purity = 1 - 






+ 0.0405) 0.021, 0.0108, (0.0087,  0.3847) 3.0201, 7314, 2. 1.07146, 0.5301, 0.394, 0.3448, 0.3603, (0.1567,



















ity: 1.7397, 81.1195; 
Product 9 purity = 1 - 
Non-product peaks intensity: 0.0237, 0.0331, 0.0318, 0.1321, 0.1244, 0.3592, 0.0405, 0.037
0.0802; 
Product 9 peaks intens
∑ ∑
∑
+ 81.1195) (1.7397,  0.0802) 0.0378, 0.0405, 0.3592, 0.1244, 0.1321, 0.0318, 0.0331, 
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